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Abstract 
Methionine (Met) is an essential amino acid because mammals cannot synthesize 
homocysteine. Betaine-homocysteine methyltransferase (BHMT) and BHMT-2 methylate 
homocysteine to form methionine using betaine and S-methylmethionine, respectively. Betaine is 
produced de novo from choline and is also found in the diet, whereas S-methylmethionine is only 
made in plants and fungi and so must be obtained from the diet. These enzyme activities are only 
be detected in the liver of adult rodents, but in adult humans and pigs, these activities are found 
in both the liver and kidney cortex. Since both pigs and humans are omnivores and share the 
same pattern of BHMT and BHMT-2 expression, the pig represents an excellent model for 
studying the physiological roles of these enzymes in human biology. 
As a prelude to investigating the influence of diet and development on the expression of 
porcine BHMT and BHMT-2, their full-length cDNAs were cloned and sequenced, and their 
corresponding genes were characterized. The genes are adjacent to each other on the same 
chromosome, and to study the evolutionary relationship between them, all the available 
sequences from 37 species of deuterostomes were analyzed.  Unlike BHMT, the BHMT-2 gene is 
not found in sea urchins, amphibians, reptiles and birds, indicating it was derived from BHMT 
following a gene duplication event in mammals. These findings imply that the BHMT-2 gene 
may offer an advantage to mammals in scavenging Met from the environment.   As expected 
based on enzyme activity data from humans and pigs, BHMT and BHMT-2 mRNAs were 
observed to be highly expressed in liver and kidney cortex, whereas there is comparatively very 
little expression in other organs.  The BHMT mRNA was higher in liver than kidney cortex (3:2 
ratio), but the BHMT-2 mRNA was more abundant in kidney cortex than liver (3:1 ratio).  
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The expression of BHMT mRNA was studied further. A total of ten different BHMT 
splice variants were observed in adult liver, kidney cortex, kidney medulla, lungs, heart, brain 
and fetal lungs. These included two variants that if translated would encode a truncated form of 
BHMT.  BHMT mRNA expression was quantified during development at gestational week 30 
(G30), G45, G90, and adult tissues.  BHMT was low in G30 whole embryos, but was found to be 
easily quantifiable and progressively increased in the liver and kidney at and after G45.  BHMT 
activity also progressively increased with age in both organs. The truncated transcripts 
represented ~10% of the total BHMT mRNA in the G30 fetus, the G45 liver and adult liver and 
kidney cortex. A computer-generated model of the truncated BHMT protein revealed a 
horseshoe fold structure of the protein, but the function of this putative protein is unknown. 
Using bisulfite sequencing, three CpG sites and the promoter region of the BHMT gene were 
identified that were more methylated in adult lungs compared to adult liver, suggesting that DNA 
methylation may be an important factor in the regulation of BHMT expression during 
development. 
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Chapter 1 
 
Introduction and Literature review 
Introduction 
Increased levels of plasma homocysteine have been associated with various diseases 
such as cardiovascular disease, renal insufficiency, psoriasis, osteoporosis, schizophrenia, 
non-insulin dependent diabetes, placental abruptions, spina bifida, Alzheimer’s disease and 
dementia. Three enzymes are responsible for the conversion of homocysteine (Hcy) to Met: 
BHMT, methionine synthase (MS) and BHMT-2. BHMT accounts for 50% of this 
conversion. Interestingly BHMT is one of the slowest enzymes known with a low catalytic 
rate that is compensated for by the presence of high amounts of BHMT enzyme (constituting 
1% of total liver protein). Rodents have been widely used to study the BHMT and BHMT-2 
genes. Rodents differ from humans in tissue expression of BHMT protein. Thus, there is 
need for an animal model that recapitulates human BHMT and BHMT-2 functions during 
development. The presence of BHMT in extrahepatic tissues where there is absence of 
betaine suggests a possible new role of BHMT.  BHMT enzymes are involved in one carbon 
metabolism. Met is converted into methyl co-factor S-adenosylmethionine (SAM) that is 
used in a number of reactions including phosphatidylcholine synthesis, creatine synthesis, 
DNA and histone methylation, etc. This reaction yields Hcy, which is catabolized or 
converted to Met. During fetal development methylation plays an important role and has 
been associated with many human diseases occurring later in life (eg. cancer). Thus, 
understanding the regulation of BHMT gene during development may provide insights in the 
additional function(s) and importance of BHMT. 
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Homocysteine & Associated Diseases 
Hcy is a sulfur amino acid involved in one carbon metabolism. Studies on association of 
elevated levels of Hcy and diseases began in the early 1960s. Since then interest in Hcy 
metabolism has increased as elevated levels of this amino acid in plasma (i.e. 
hyperhomocysteinemia; HHcy) have been associated with increased risk for cardiovascular 
disease, psoriasis, renal insufficiency and Alzheimer's disease (Ueland and Refsum, 1989; 
Pajares and Perez-Sala, 2006; Mizrahi et al., 2002).  
Betaine is administered as Hcy-lowering therapy for people with HHcy due to inborn 
errors in Hcy metabolism (Wilcken et al., 1983). A meta-analysis which examined 30 studies 
confirmed that increased plasma Hcy level is an independent predictor of ischemic heart disease. 
Studies have shown that HHcy is a stronger risk factor in patients suffering from non-insulin 
dependent diabetes and in patients with existing coronary heart disease (Hoogeveen et al., 2000; 
Okada et al., 1999; Nygard et al., 1995). Metabolic regulation of plasma Hcy is altered in 
diabetes. The enzymatic activities of two enzymes viz. cystathione beta-synthase and BHMT 
change during diabetes due to the direct effect of insulin and counter-regulatory hormones 
(Wijekoon et al., 2007).  
HHcy also has been associated with adverse pregnancy outcomes, including spina bifida 
and placental abruptions (Chadwick et al. 2000, Ananth et al. 2007, Steegers-Theunissen et 
al.,1991; Hague 2003).  Recently, a study demonstrated the association between a homozygous 
mutant form of human BHMT polymorphism and increased risk of placental abruption (Ananth 
et al. 2007).  Another study revealed the presence of twenty-five single nucleotide 
polymorphisms (SNPs), which included four non-synonymous SNPs in BHMT and thirty-nine 
SNPs, of which four were non-synonymous SNPs in BHMT2 in humans (Shaw et al. 2009). 
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However, there were no significant changes in enzyme activity between the variant alloenzymes 
of BHMT and wild type BHMT enzyme. Significant differences, however in Km values were 
detected (Shaw et al. 2009). The BHMT rs3733890 polymorphism has been associated with 
reduced breast cancer-specific mortality (Xu et al., 2009). 
 
Homocysteine Metabolism 
The metabolism of Hcy is shown in Figure 1.1.  Hcy can participate in the trans-
sulfuration pathway, which results in the formation of cysteine, or it can be methylated to reform 
Met, the amino acid from which it was originally derived.  The conversion of Hcy to Met is 
referred to as remethylation, a process that is critical for cell function since the dietary intake of 
Met cannot meet the supply of methyl groups needed for the volume of downstream S-adenosyl 
methionine (SAM)-dependent methyltransferase reactions.  Quantitatively, most of the SAM-
derived methyl groups are required for phosphatidylcholine and creatine biosynthesis. Scores of 
other SAM-dependent methyltransferases are known to exist, including the DNA 
methyltransferases that have an important role in the regulation of gene expression.   
HHcy can result from deficiencies of the vitamin-derived coenzymes required for normal 
Hcy metabolism (folate, vitamin B6 and vitamin B12), or genetic mutations and/or 
polymorphisms in the genes that encode enzymes essential for normal trans-sulfuration or 
remethylation rates. Most notable among the genetic causes of HHcy are those that result in the 
catastrophic loss of cystathionine β-synthase (CBS) (Wantanabe et al., 1995) or 
methylenetetrahydrofolate reductase (MTHFR) activities, or defects in the Cbl genes required to 
sustain methylcobalamin-dependent Met synthase (MS) activity.  Dramatic loss of CBS, 
MTHFR or MS function not only cause severe HHcy, but also homocystinuria, a disease that 
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displays wide genetic heterogeneity and can result in severe mental retardation and gross 
perturbations in physical development. To date, a mutation or polymorphism in BHMT or 
BHMT-2 that results in HHcy has not been discovered, but recently it was shown that treating 
mice with a highly specific and potent inhibitor of BHMT caused severe HHcy and a reduction 
of liver SAM (Collinsova et al. 2006). BHMT is associated with alcoholic liver steatosis and 
injury. The BHMT enzyme is known to directly protect hepatocytes from Hcy induced injury 
(Cheng Ji et al., 2007). 
 
BHMT Enzyme 
The BHMT protein has been studied since the late 1950s. BHMT is a zinc-dependent 
methyltransferase that methylates thiols or selenols (Breksa, Garrow 1999). The BHMT enzyme 
belongs to Pfam 02574 and is a tetramer catalyzing an ordered bi bi reaction; Hcy binds, then 
betaine (trimethylglycine), and after catalysis dimethylglycine is the first product released 
followed by Met.  Humans derive betaine from food sources like wheat, spinach, shellfish and 
sugar beets (Sakamoto et al., 2002; Zeisel et al., 2003). Alternatively, betaine can be formed 
from choline (Ueland et al., 2005).  
The BHMT enzyme is strongly inhibited by dimethylglycine because the enzyme can 
form a dead-end ternary complex by binding Hcy and dimethylglycine (Castro et al., 2004).  Met 
is a weak competitive inhibitor of Hcy binding. The crystal structure of several bacterial MS 
enzymes, and human and rat BHMT have been solved (Evans et al., 2002, Garrido et al., 2005).  
The structure of MS and BHMT enzymes differ substantially except they share determinants for 
Hcy and zinc binding.  The essential structural features of BHMT include an N-terminal (β/α)8 
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barrel (residues 1-319) that contains the catalytic zinc and substrate binding determinants, and a 
C-terminal region  (residues 320-406/407) that is required for oligomerization. 
 
Distribution of BHMT enzyme 
The distribution of the Hcy remethylation enzymes in adult tissues and organs has been 
the subject of numerous studies (Delgado-Reyes et al., 2001; Chadwick et al., 2000; Finkelstein 
and Martin, 1984).  MS synthase is constitutively expressed in all adult tissues, although it is 
found in extremely low abundance, and has a turnover number of 670 min-1 from pig liver and 
specific activity of 0.9 µmol min-1 mg protein.  In contrast, BHMT enzymes represent some of 
the slowest enzymes known (turnover is 9 min-1) and their activities are only detected in a 
limited number of adult animal organs. In liver, BHMT expression has been shown to be 
influenced by diet (Park and Garrow, 1999) and can reach 1-1.6% of the total soluble protein.  
Rats fed diets deficient in Met containing supplemental betaine can have BHMT mRNA and 
activity levels that are fivefold greater than control animals (Park and Garrow, 1999). These diet-
induced changes are at least in part due to changes in hepatic SAM concentrations since elevated 
levels of SAM have been shown to inhibit BHMT transcription (Lu et al. 2001). In addition to 
being present in adult liver, BHMT is expressed in high abundance in the pancreas of ruminants 
and guinea pigs, and in the kidney cortex of guinea pigs, pigs and primates (Delgado-Reyes et 
al., 2001; Delgado-Reyes and Garrow, 2005).  In humans and pigs, BHMT activity in kidney 
cortex is nearly as high as it is in liver.  BHMT is also expressed in the Rhesus monkey lens (Rao 
et al., 1998). 
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Regulation and Interaction of BHMT 
BHMT activity in liver has been shown to be dependent on diet. Increases in BHMT 
mRNA and activity have been reported when supplemented with Met, choline, betaine and 
cysteine. A decrease in BHMT activity has been observed in selenium deficient diets. Tubulin, 
lysosomal membranes and transglutaminases have been demonstrated to directly interact with 
BHMT protein (Sandu et al., 2000; Furuya et al., 2001). These data suggest the possibility that 
BHMT is modified post-translationally; thereby, acquiring different folding patterns that would 
be responsible for various role of BHMT protein (Pajares and Perez-Sala, 2006). 
 
BHMT-2 Enzyme 
In contrast to BHMT, the existence of the BHMT-2 gene was just observed in 2000 
(Chadwick et al., 2000).  Because of its homology with BHMT it was assumed to methylate Hcy 
using betaine.  However, it was recently shown that BHMT-2 methylates Hcy using S-
methylmethionine (SMM) and does not use betaine as a methyl donor.  Furthermore, unlike 
BHMT, BHMT-2 is a monomeric protein (Szegedi et al. 2008).  These structural and functional 
characteristics are similar to the SMM-dependent methyltransferases described in single cell 
organisms.  Since SMM is only made by plants and lower organisms, from a teleological 
perspective it appears that BHMT-2 was retained by mammals to scavenge as much Met from 
the environment as possible.  Most of the structural elements required for oligomerization in the 
C-terminal region of BHMT are missing in BHMT-2, explaining its monomeric nature. 
When the BHMT-2 gene was first discovered, its mRNA was reported to be very high in 
the liver and kidney but much lower levels were observed in the brain, heart and skeletal muscle 
of mouse and human tissues (Chadwick et al., 2000). Despite detecting mRNA for BHMT-2 in 
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some extrahepatic tissues, BHMT-2 activity could only be detected in the liver of mice and rats. 
No other studies have attempted to measure BHMT-2 activity in organs of non-rodent species 
(Szegedi et al., 2008).  BHMT-2 activity is only detected in the liver of rodents.  In pigs, guinea 
pigs and primates, BHMT activity is only detected in adult liver and kidney cortex and BHMT-2 
activity has not yet been observed in organs from these species. BHMT-2 differs from BHMT at 
the amino acid sequence in the N-terminal region that confers the ability to use betaine as a 
methyl donor (Miller et al. 2005), and amino acid sequence in the C-terminal region allowing 
oligomerization (Szegedi and Garrow, 2004; Evans et al., 2002) 
 
             Impact of Homocysteine Metabolism on Methylation 
Dietary deficiency of folate, choline, Met or vitamin B-6 can disrupt one-carbon 
metabolism and Hcy regulation. Polymorphisms in enzymes associated with one carbon 
metabolism pathways interact with the above nutrient deficiencies and could promote disease 
(Bailey et al., 1999; Rock et al., 2000; James et al., 2002). HHcy is accompanied by increased 
level of SAH which affects cellular methylation in humans (Gonzales et al., 2001). During 
pregnancy plasma betaine declines until gestational week 20 and then remains constant. After 
gestational week 20, plasma betaine has been shown to have an inverse relationship with plasma 
total Hcy (Ueland et al., 2005). The human oocyte has been shown to regulate Hcy level using 5-
methyltetrahydrofolate-homocysteine methyltransferase and BHMT (Benkhalifa et al., 2009).  
Thus, all the above factors are associated with shaping the biochemical make-up of an individual 
and can affect cellular methylation during development.  
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Knockout Models 
Untill now, no knockout animal models have been established for BHMT genes. 
However, BHMT activity and regulation has been studied in knockout mice for other enzymes 
involved in one carbon metabolism. BHMT activity has been shown to increase in MTHFR (-/-) 
whereas no change was observed in CBS (+/-) model (Pajares and Perez-Sala, 2006).  
 
The Pig as an Animal Model to Study BHMT Functions/Regulation 
 For the past several decades rodents like mice and rats have been widely used as animal 
models to study various diseases in humans. In order to extrapolate the results to humans the 
animal model should biochemically, physiologically and metabolically represent humans. Also, 
the disease to be studied needs to be reproducible with similar signs and symptoms in the model 
organism. Thus, selection of the animal model depends on the disease to be studied.  
            Due to recent advances in whole genome sequencing in human, rat, mouse and pig; it has 
been demonstrated that the pig genome is 60% similar to the human genome as compared to 40% 
similarity between rodents and humans (Thomas et al., 2003). Pigs are also similar to humans in 
body mass compared to rodents and hence have been used for biomedical imaging and tissue 
engineering studies (Lunney, 2007). Compared to rodents, pigs have a longer lifespan of ~10-15 
years so that disease progression can be studied over a longer time period than in rodents (Hau, 
2003). The gestational development of pig fetus is physiologically similar to human fetal 
development (Book and Bustad, 1974).  
 The pig has been used to as a biomedical model to study diseases such as cardiovascular 
disease (Turk and Laughlin,2004; Turk et al., 2005; Ambrose 2006; Boluyt et al., 2007; Lai et al 
2006), Alzheimer’s disease (Kragh et al., 2008), psoriasis (Malerba et al., 2006) amongst many 
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others. All these diseases are associated with Hcy metabolism. Additionally, BHMT is expressed 
in similar tissues (liver and kidney cortex) in humans and pigs.  
 
Project Summary 
Increased levels of plasma Hcy have been associated with diseases affecting all stages of 
development: gestation (placental abruptions and spina bifida), adulthood (cardiovascular 
disease, renal insufficiency, psoriasis, osteoporosis, schizophrenia, non-insulin dependent 
diabetes melitus) and old age (Alzheimer’s disease and dementia). Combined these diseases have 
a huge impact on health care expenditures.  
BHMT and BHMT-2 convert Hcy to Met using betaine and S-methylmethionine as 
substrates, respectively. BHMT and BHMT-2 have been widely studied but their role during 
development and their evolutionary history have not been addressed. Although much has been 
learned about the BHMT enzymes over the last decade, several perplexing issues still remaim.  
First, what evolutionary constraint put pressure on BHMT to remain so catalytically inefficient, 
and yet compensate for its poor catalytic activity by greatly overexpressing this enzyme in liver 
and kidney cortex? Second, is there a role for the BHMT mRNA is detected in extrahepatic 
tissues where no enzyme activity can be detected, suggesting that splice variants are either not 
translated or encode proteins without methyltransferase activity? These issues suggest the 
possibility of cellular role(s) for BHMT independent of methyltransferase activity. We therefore 
propose the following experiments to better understand the evolutionary history of BHMT and 
BHMT-2 to help elucidate the regulatory mechanisms controlling the expression of BHMT and 
BHMT-2 and to help define any role these genes have in these diseases and provide insights into 
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treatment, and to address our hypothesis that regulation of the BHMT gene (splice variants) 
contributes to multiple developmentally relevant functions (disease). We therefore decided to 
evaluate the pig as a model to study BHMT function during development. These results could be 
utilized to recapitulate human BHMT functional studies and also to provide a basis for further 
studies of BHMT and disease states.  Our specific aims were as follows: 
 
Specific Aim #1: Identification of an appropriate animal model to study BHMT and BHMT-2 
genes. 
 An appropriate animal model would recapitulate human BHMT and BHMT-2 function(s) 
to support developmental studies. Previous studies have shown that the tissue expression of 
BHMT enzyme is similar in humans and pigs (liver and kidney cortex) whereas in rodents (mice 
and rats) BHMT enzyme is highly expressed in liver only. The reason for this difference in 
expression is as yet unknown. Studies have shown that BHMT liver expression is dependent on 
diet. Pigs and humans are omnivores; hence have a similar dietary pattern. Currently the pig is 
used as a model to study many human diseases and organ transplantation. The pig is also 
anatomically, metabolically and physiologically similar to humans (Chen et al. 2007). Thus, the 
pig would represent a potentially suitable model for the evaluation to study BHMT genes. 
 
Specific Aim # 2: Identification of spatial and temporal changes and the regulation of BHMT and 
BHMT-2 gene and protein expression. 
High levels of plasma Hcy have been associated with many diseases. BHMT and BHMT-
2 convert Hcy to Met. BHMT is known to be an abundant liver protein (~1% of total liver 
protein). The abundance suggests that BHMT may have multiple functions during development. 
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The changes in tissue expression of BHMT and BHMT-2 suggest differential regulation of these 
genes. Our goal is to determine the epigenetic mechanism regulating the expression pattern of 
BHMT genes spatially and temporally. Methylation is one of the mechanisms, which can affect 
the expression of an enzyme. These studies could help us reveal possible role(s) of these 
enzymes during development in addition to the methyltransferase activity. 
 
Specific Aim # 3: Determine the evolutionary history of BHMT gene and estimate time of gene 
duplication and genetic divergence. 
 Hcy is converted to Met by three enzymes: methionine synthase, BHMT and BHMT-2. 
BHMT is present in high amounts; approximately 1% of total liver protein (β-actin is 10% of 
total liver protein) and accounts for 50% of conversion of homocysteine to Met. Methionine 
synthase is catalytically more active than BHMT. Thus, it is important to understand the 
evolutionary constraints on BHMT to remain catalytically inefficient while compensating for its 
poor catalytic activity through overexpression in the liver and kidney cortex. 
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Figures 
 
 
 
Figure 1.1: Homocysteine metabolism. Abbreviations: Bet, betaine; CH2THF, methylene 
tetrahydrofolate; CTH, cystathione; Cys, cysteine; DMG, dimethylglycine; Hcy, homocysteine; 
Met, methionine; SAH, S-adenosylhomocysteine; SAM, S adenosylmethionine; Ser, serine; 
THF, tetrahydrofolate; αKB, alphaketobutyrate. Reactions: 1, methylenetetrahydrofolate 
reductase (MTHFR); 2, methionine synthase; 3, betaine-homocysteine methyltransferase 
(BHMT); 4, BHMT-2; 5, methionine adenosyltransferase; 6, SAM-dependent methyltransferase 
reactions (many); 7, SAH hydrolase; 8, cystathionine β-synthase (CBS); 9, cystathionase. 
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Chapter 2. Molecular characterization and analysis of the porcine  
BHMT and BHMT-2 genes 
Abstract 
Betaine homocysteine methyltransferase (BHMT) and BHMT-2 enzymes convert homocysteine 
to methionine using betaine and S-methylmethionine, respectively. These enzymatic activities 
are observed only in the liver of adult rodents; whereas in adult humans and pigs BHMT activity 
is detected in both the liver and kidney cortex.  Due to this shared pattern of enzyme activity, the 
pig may represent a more appropriate model for studying the biochemical and physiological roles 
of these enzymes in human biology. Porcine BHMT and BHMT-2 cDNA were cloned and 
sequenced, and their 5’ and 3’ UTRs were amplified using RLM-RACE. The BHMT transcript 
had longer 5’ and 3’ UTRs, consisting of 77 and 1,142 nucleotides, respectively, whereas the 
BHMT-2 5’ and 3’ UTR consisted of 17 and 893 nucleotides, respectively. Based on the 
alignment of these mRNAs with pig genomic sequences using the ensembl database, it was 
determined that both the pig BHMT and BHMT-2 genes span approximately 26kb and 16kb, 
respectively. Both the BHMT and BHMT-2 genes consist of 8 exons and 7 introns similar to that 
observed in human, rat and mouse genes. The deduced amino acid sequences of BHMT and 
BHMT-2 contained 407 and 363 amino acids, respectively, and shared 78% amino acid identity 
which included the homocysteine binding domain and cysteine residues responsible for Zn 
binding.  Relative to BHMT-2, BHMT has two additional amino acid sequences, a 9 amino acid 
N-terminal sequence (86-94) which confers betaine binding specificity and a 34 amino acid 
sequence at the carboxy terminus (373-407) which is responsible for tetramerization of the 
BHMT enzyme.  No promoter element (TATA or CAAT box) was observed for either BHMT or 
BHMT-2 genes. A CpG island was observed for BHMT and BHMT-2 genes; surrounding the 
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promoter and transcriptional start site implying that methylation could regulate expression of 
BHMT and BHMT-2 genes in various tissues and/or during development. Using qPCR, BHMT 
transcripts were shown to be expressed 1.5-fold higher in liver than kidney cortex. The kidney 
medulla and the lungs expressed 4- and 39-fold lower BHMT transcripts, respectively; whereas 
the heart and brain contained negligible levels of BHMT transcript as compared to kidney cortex. 
However BHMT-2 transcript levels were expressed 3 fold higher in the kidney cortex than liver. 
The level of BHMT-2 transcript expression in the kidney medulla, lungs, heart and brain was 
negligible compared to the kidney cortex. These findings confirm that the expression pattern of 
BHMT and BHMT-2 genes in pigs is similar to humans and further supports the use of the pig as 
an appropriate animal model to study diseases and gene regulation associated with BHMT and 
BHMT-2 genes. 
Radhika S. Ganu, Timothy A. Garrow, Monika Sodhi, Laurie A. Rund, Lawrence B. Schook (2010). 
Molecular characterization and analysis of the porcine betaine homocysteine methyltransferase and 
betaine homocysteine methyltransferase -2 genes. Gene (Accepted) 
 
Introduction 
Elevated levels of plasma homocysteine, i.e. hyperhomocysteinemia (HHcy), have been 
associated with increased risks for vascular disease, psoriasis, renal insufficiency and 
Alzheimer's disease (Ueland and Refsum, 1989; Pajares and Perez-Sala, 2006; Mizrahi et al., 
2002).  HHcy also has been associated with adverse pregnancy outcomes, including spina bifida 
and placental abruptions (Steegers-Theunissen et al.,1991; Hague 2003).  Due to its association 
with human diseases, the study of the genetic and nutritional factors influencing plasma Hcy 
levels have been the subject of intense study over the past 20 years.  More recently BHMT-2 
gene was discovered, which encodes an enzyme not using betaine as a substrate, a metabolite 
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produced de novo, but rather the plant metabolite, S-methylmethionine. This discovery has 
sparked new interest in the role BHMT enzymes perform in sulfur amino acid metabolism across 
the spectrum of mammalian development as well as how animals adapt to securing adequate 
amounts of Met from diverse nutritional sources.  
Hcy lies at a metabolic branch point, where it either participates in the transsulfuration 
pathway (thereby contributes a sulfur atom required for cysteine biosynthesis) or it is methylated 
to re-form Met, the amino acid from which it was originally derived.  The conversion of Hcy to 
Met is referred to as remethylation, a process that is critical for cell function since the need for 
Met in downstream S-adenosylmethionine (SAM)-dependent methyltransferase reactions is 
robust and must continue during postprandial and fasting conditions. Three enzymes can 
methylate Hcy: methionine synthase (MS), BHMT and BHMT-2. Quantitatively, the majority of 
the SAM-derived methyl groups are used in phosphatidylcholine and creatine biosynthesis, but it 
has been estimated that the human genome contains ~200 genes encoding SAM-dependent 
methyltransferases (Petrossian and Clarke, 2010). 
 MS is ubiquitously expressed (Chen et al., 1997) but the distribution of BHMT 
enzymatic activity is more restricted and has been the subject of numerous studies using adult 
animals (Delgado-Reyes et al., 2001 and references therein).  BHMT and BHMT-2 enzymes 
have very low turnover numbers (~10/m) and so using enzyme activity assay only detects 
expression in limited number of adult organs.  In mammalian liver, BHMT expression has been 
shown to dramatically increase during Met deficiency (Park and Garrow, 1999) and reportedly 
represents 1% or more of the total soluble protein (Garrow 1996).  In addition to being present in 
adult liver, BHMT also is observed in high abundance in the pancreas of ruminants and guinea 
pigs, and in the kidney cortex of guinea pigs, pigs and primates (Delgado-Reyes et al., 2001; 
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Delgado-Reyes and Garrow, 2005).  In humans, pigs and guinea pigs, BHMT activity within the 
kidney cortex is nearly as high as that observed in liver and has been specifically localized by 
immunohistochemistry to the proximal tubules.  Similarly, BHMT-2 mRNA has been shown to 
be expressed at significant levels in the liver and kidney with comparatively lower levels of 
expression detected in the brain, heart and skeletal muscle of human tissues (Chadwick et al., 
2000). Despite the detection of BHMT-2 transcripts in extrahepatic tissues, BHMT-2 activity has 
only been observed at significant levels in the livers of mice and rats (Szegedi et al., 2008).  It is 
unknown whether the diet influences BHMT-2 gene expression in any organ, and further study is 
required to determine whether diet impacts BHMT expression in kidney and pancreas.  Besides 
being important for the methylation of Hcy, BHMT enzyme is also required in the degradation of 
betaine to glycine.  This is important since betaine functions as an intracellular organic osmolyte 
whose concentrations are regulated by cell tonicity (Burg et al., 2007). For example, studies in 
guinea pigs have shown that high salt intake results in a dramatic decrease in BHMT mRNA and 
protein abundance in both liver and kidney cortex (Delgado-Reyes and Garrow, 2005). 
This study provides the first characterization of the pig BHMT and BHMT-2 gene 
structures and their complete cDNA sequences.  Since pigs and humans are omnivores and both 
express BHMT enzymes in the same adult organs, we anticipate utilizing the pig as an animal 
model to explore the spatial and temporal expression of the BHMT enzymes throughout 
development as well as the physiological genetics of the BHMT enzymes in human health and 
disease.  The isolation and characterization of the BHMT and BHMT-2 genes provides essential 
information required to further investigate this area of sulfur amino acid biology.  
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Materials and Methods 
 
Porcine RNA isolation and cDNA synthesis 
Liver, kidney cortex, kidney medulla, lungs, heart, and brain tissues were obtained from 
three Yorkshire pigs aged 7months and in fasted state.  Total RNA was isolated from frozen 
tissues using a RNeasy Mini Kit (Qiagen, Valencia, CA).  Reverse transcription was carried out 
using random primers and a Bioline cDNA synthesis kit (Bioline, Taunton, MA).  
 
Full-length porcine BHMT and BHMT-2 cDNA cloning and sequencing 
The porcine BAC clone (CU468550) encoding both porcine BHMT and BHMT-2 genes 
were identified by searching human BHMT and BHMT-2 nucleotide sequences against the 
porcine genome (http://www.sanger.ac.uk/Projects/S_scrofa/). Using the blast search routine the 
intron-exon junctions were located using the SPIDEY tool 
(http://www.ncbi.nlm.nih.gov/spidey/).  Three primer sets (Table 1): 1-F, 1-R; 2-F, 2-R; 3-F and 
3-R, based on the exonic regions of the BHMT gene, were used to amplify three overlapping 
cDNAs that encoded the complete ORF of BHMT.  The amplicons were cloned into pCR2.1-
TOPO (Invitrogen, Carlsbad, CA) and sequenced using ABI Prism® BigDye™. Similarly, two 
overlapping cDNAs that encoded the complete ORF of BHMT-2 were obtained using the 
following primer sets:  4-F, 4-R; 5-F and 5-R (Table 1).  
The 5’ and 3’ untranslated regions of BHMT and BHMT-2 were amplified using total 
RNA and the FirstChoiceTM RNA ligase-mediated (RLM)-RACE kit (Ambion, Austin, TX).  
This procedure used primers supplied with the kit and the nested gene-specific primers listed in 
Table 1.  The full-length cDNA sequences of porcine BHMT (accession number: HQ130333) and 
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BHMT-2 (accession number: HQ130334) were submitted to NCBI Genbank. Comparative 
analysis of cDNA sequences and predicted protein sequences were carried out using Biology 
Workbench (http://workbench.sdsc.edu/).  MFOLD program, version 3.2 developed by Zuker 
and Turner (2003); (http://www.bioinfo.rpi.edu/applications/mfold) was used to predict 
secondary structures and calculate free energy values.  The promoter region was predicted using 
Proscan software (http://www-bimas.cit.nih.gov/molbio/proscan/) and TSSG software 
(http://www.softberry.ru/berry.phtml).  The transcriptional binding sites were identified using 
TESS (http://www.cbil.upenn.edu/cgi-bin/tess/tess) and TFSearch engine 
(http://www.cbrc.jp/research/db/TFSEARCH.html). The repeat elements were detected using the 
repeatmasker software (http://repeatmasker.org/cgi-bin/WEBRepeatMasker) Microsatellite 
repeats were identified using Gramene software (http://www.gramene.org/db/markers/ssrtool). 
Poly AH software (http://www.softberry.ru/berry.phtml) was used to detect 3’ UTR poly A 
signal sites. SMART (http://smart.embl-heidelberg.de/), Scanprosite 
(http://expasy.org/tools/scanprosite/) and Pfam programs were used to predict the domain and 
motifs of BHMT and BHMT-2 proteins. 
 
Real time qRT-PCR of porcine BHMT and BHMT-2 transcripts 
The BHMT and BHMT-2 transcripts were quantified by qRT-PCR using the SYBR® 
GreenER™ PCR Mastermix (Invitrogen, Carlsbad, CA).  Each tissue was collected from 
three pigs and for each sample three replicates were performed.  Total mRNA was treated 
with RNase-free DNAse (Qiagen, Valencia, CA) to eliminate genomic contamination.  
Reverse transcription was then performed with OmniscriptKit (Qiagen, Valencia, CA) using 
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the protocol of Chen et al. (2006).  Primers (Table 2) were designed using Primer Express 
software (Applied Biosystems, Foster city, CA).  The total number of BHMT and BHMT-2 
transcripts in a given tissue was determined using the following primer sets; BHMT-f and 
BHMT-r, and B2-f and B2-r, respectively.  Total 18s rRNA was used as an internal control 
(Chen et al. 2006) and each reaction contained 100ng of cDNA. Negative controls (minus 
template or reverse transcriptase) were also run in triplicate. Absolute copy number as well 
as normalized values were determined individually for each transcript. PCR products were 
cloned into pCR2.1-TOPO (Invitrogen, Carlsbad, CA) vector, verified by sequencing then 
used for the construction of a standard curve. RT- PCR assays were performed using the ABI 
7900HT fast real time PCR system (Applied Biosystems, Foster City, CA).    
 
Results 
 
Analysis and genomic organization of porcine BHMT and BHMT-2 genes 
  Complete genomic sequences of porcine BHMT and BHMT-2 genes were 
determined from the BAC clone CU468550. A schematic representation of the BHMT 
and BHMT-2 genes is shown in Fig. 2.1 and exonic region details are provided in Table 
2.3. The BHMT gene spans 26,508 bp and includes 77 bp of 5’ UTR, 1,142 bp of 3’ UTR 
and 1,224 bp of coding region.  The BHMT-2 gene spans 15,997 bp and includes 17 bp of 
5’ UTR, 893 bp of 3’ UTR and 1,092 bp of coding sequence (Ganu et al. 2009). The 
BHMT gene (Table 4) has 9,996 bp (37.7%) of interspersed repeats, including 5,088 bp of 
short interspersed nuclear elements (SINEs-19.19%), 3,295 bp of long interspersed 
repeats (LINEs-12.43%), 433 bp long terminal repeats (LTR-1.63%) and 1,180 bp of 
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DNA elements (4.45%).  The BHMT-2 gene (Table 2.4) has 5,514 bp (34.47%) of 
interspersed repeats that include 3,049 bp short interspersed elements (SINEs 19.06%), 
1,631 bp long interspersed repeats (LINEs 10.2%), 615 bp LTR (3.84%) and 219 bp 
DNA elements (1.37%). Five microsatellite markers were identified within the BHMT 
gene; introns 1, 5 and 7 each have one, and intron 2 contains two microsatellites.  Two 
microsatellite markers were found in the BHMT-2 gene, one in intron 2 and one in intron 
3. Each of these microsatellite markers are di-nucleotide repeats of varying numbers 
ranging from 5-25 (Table 2.5). 
 
 Analysis of porcine BHMT and BHMT-2 cDNAs and deduced amino acid 
sequences    
A RLM-RACE protocol was used to amplify cDNA sequences of BHMT gene 
using total RNA isolated from adult liver.  The complete ORF of the BHMT gene was 
1,224 bp long and encoded a protein of 407 amino acids with a calculated MW of 45 kD 
and a theoretical isoelectric point (pI) of 7.22. The ORF of the BHMT-2 gene was 1,092 
bp long and encoded a 363-residue protein with a calculated MW of 40 kD and a 
theoretical pI of 6.86.  
   The comparison of porcine BHMT amino acid sequence across different 
species revealed that porcine BHMT shared 94.8%, 96.3%, 93.6% and 95.6% amino acid 
identity with human (NM_001713), bovine (AY854632), rat (NM_030850) and mouse 
(AF033381) BHMT, respectively.  The porcine BHMT-2 had 88.2%, 86.5% and 87.6% 
amino acid homology with human (NP_060084), rat (NM_001014256) and mouse 
(AF257474) BHMT-2, respectively. Thus, BHMT and BHMT-2 enzymes are highly 
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conserved in mammals. The porcine BHMT and BHMT-2 protein shared 78% amino 
acid identity. Relative to BHMT-2, BHMT has two additional sites of amino acid 
sequences: a 9 amino acid insertion (residues 86-94) at the N-terminus and a 34 amino 
acid sequence (residues 373-407) at the carboxy terminus (Fig. 2.2).  The porcine BHMT 
and BHMT-2 enzymes belong to the family of S-methyltransferases enzymes (PF02574). 
Scanprosite amino acid sequence analysis software predicted that both BHMT and 
BHMT-2 have a Hcy-binding domain (PS50970) containing a zinc binding motif 
encoded by cysteines 217, 299 and 300.  The role of C217, C299 and C300 in zinc 
binding and catalysis have been confirmed by site-directed mutagenesis (Breksa and 
Garrow, 1999) and elucidation of the crystal structures of the human (Evans et al., 2002) 
and rat enzymes (González et al. 2002; González et al. 2004). The amino acid sequence 
analysis also predicted that the BHMT protein had seven N-myristoylation sites 
(PS000008), five protein kinase C phosphorylation sites (PS0005) and four casein kinase 
II phosphorylation sites (PS00006).  The porcine BHMT-2 enzyme was predicted to 
contain seven concensus N-myristoylation sites (PS000008), six protein kinase C 
phosphorylation sites (PS0005) and five casein kinase II phosphorylation sites 
(PS00006). 
 
Promoter region and 5’UTR  
 The tissue-specific expression of BHMT and BHMT-2 in adult tissues could be 
the result of regulation at the promoter and/or 5’ UTR region.  The leader sequences were 
predicted to have secondary structures with free energies of – 19.5 kcal/mol for the 
BMHT protein and –2.6 to –3.2 kcal/mol for the porcine BHMT-2 enzyme.  A BLAST 
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search using the NCBI porcine resources identified one EST (AK233096) that was 
homologous to the porcine BHMT gene and contained a 5' UTR that was 532 bases 
longer than the porcine BHMT transcript reported here.  This suggested that there may be 
more than one mRNA splice variant, a possibility that warrants further investigation.   
   A putative TATA-less promoter was present in intron 1 of the porcine BHMT 
gene that is 541 bases downstream of the transcriptional start site.  For the porcine 
BHMT-2 gene, a predicted promoter region (250 bases) was found between –194 and +56 
relative to the translational start site.  The region from 1-56bp includes the entire 5’ UTR 
and most of exon 1. For the porcine BHMT-2 gene also, no TATA box was predicted. 
Potential transcriptional regulatory elements which included NF-1, GATA-1, CP1, IRF-1, 
p300, GR, CdxA, LVc, Sp1, GAL4, H4TF-2, LBP-1 and HSTF were detected upstream 
and downstream from the transcriptional start site for both the porcine BHMT and 
BHMT-2 genes.  
 
Detection of CpG island in BHMT and BHMT-2 gene 
 A CpG island (865 bp with 64.9% GC content) was detected in the porcine 
BHMT gene. The CpG island started 100 bp upstream of the translational start site and 
contained exon 1 and part of intron 1. One CpG island (627 bp in length; 72% GC 
content) was also detected in the 5’ flanking region (359 bp upstream) of the porcine 
BHMT-2 gene that overlapped with the predicted promoter region (Fig. 2.1). These 
islands may represent elements of epigenetic (methylation) control of BHMT and BHMT-
2 transcription.   
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3’UTR analysis 
 The porcine BHMT cDNA contains a consensus polyadenylation signal 
(ATTAAA) in the 3’UTR resulting in a 3’ UTR length of 1,142 bp.  Also, two additional 
polyadenylation signals were detected at 530 and 1023 nucleotides downstream of the 
translational termination site in the 3’UTR. The transcripts resulting from the above 
transcription termination might potentially represent two splice variants that could not be 
cloned due to their low expression levels.  
 An additional polyadenylation signal at 90 bp upstream of the 3'UTR of 
BHMT-2 gene was also detected, suggesting the presence of splice variants. Additionally, 
a BLAST search of NCBI porcine resources identified a BHMT-2 EST (AK232714.1) 
that had 43 more bases in the 3’ UTR than the one reported here. Thus, there could be 
BHMT-2 splice variants that were not cloned, presumably either due to low expression 
levels or are expressed in tissues other than liver, kidney, lungs, heart and brain.  
 
Tissue specific expression analysis of porcine BHMT and BHMT-2 transcripts 
Quantitative real-time PCR analysis revealed that adult porcine liver has the 
highest expression of total BHMT transcripts, which is approximately 1.5-fold higher as 
compared to kidney cortex (Fig. 3).  The kidney medulla and lungs expressed 
significantly lower (4- and 39-fold lower, respectively) BHMT transcripts compared to 
kidney cortex; 307,780/100ng and 31,249/100ng of total mRNA, respectively, and the 
heart and brain contained negligible levels of BHMT transcripts as compared to kidney 
cortex.  
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In the kidney cortex BHMT-2 transcripts were abundant. Although in contrast to 
BHMT, the level of BHMT-2 transcripts were 3-fold higher in the kidney cortex 
compared to liver (Fig. 2.4). The level of BHMT-2 transcript expression in kidney 
medulla, lungs, heart and brain was negligible compared to kidney cortex. 
 
Discussion 
 
  Elevated plasma levels of Hcy have been associated with a number of diseases 
that affect various stages of life (Ueland and Refsum, 1989; Pajares and Perez-Sala, 
2006; Mizrahi et al., 2002; Hague, 2003; Ananth et al., 2007; Chen, 2008; Motulsky, 
1996).  Using a specific and high affinity inhibitor of BHMT, it has been shown that 
inhibition of this enzyme in vivo (mice) resulted in severe HHcy (Collinsova et al., 2006). 
Hence it is important to identify an appropriate animal model that recapitulates human 
BHMT and BHMT-2 function(s) to support future disease and developmental studies.   
Currently the pig is used as a model to study many human diseases and organ 
transplantation because it is anatomically, metabolically and physiologically similar to 
humans (Tumbleson and Schook, 1996; Chen et al., 2006; Chen et al., 2007; Kuzmuk and 
Schook, 2010).  Humans and pigs both have high levels of BHMT and BHMT-2 in the 
liver and kidney cortex (Chadwick et al., 2000). Studies have shown that BHMT liver 
expression is dependent on diet. Pigs and humans both being omnivores have a similar 
dietary pattern. Thus, it is clear that the pig could represent an appropriate animal model 
to study the physiological function of BHMT enzymes in health and disease, thus 
supporting the need to characterize porcine BHMT and BHMT-2 genes.  
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This study provides full-length porcine BHMT and BHMT-2 cDNAs sequences as 
well as the genomic organization of their respective genes.  A single BAC clone 
(accession number: CU468550) was identified that contained both of the porcine BHMT 
and BHMT-2 genes.  Similar to that observed in the human and mouse BHMT and 
BHMT-2 genes, the porcine genes contained 8 exons and 7 introns (Park and Garrow, 
1999).  The exonic sequences of the porcine BHMT gene shared 90%, 85%, and 86% 
nucleic acid identity with the human, rat and mouse BHMT genes.  The exonic sequence 
of the porcine BHMT-2 gene shared 87%, 82%, and 83% nucleic acid identity with the 
human, rat and mouse BHMT-2 genes. The first 957 nucleic acids code for the N-terminal 
domain of BHMT and BHMT-2 enzyme containing the enzyme active site, i.e Hcy and 
substrate binding site (Evans et al., 2002; Castro et al., 2004). Thus, BHMT and BHMT-2 
genes are conserved for the function of Hcy conversion to Met across mammals. 
The deduced amino acid sequence of porcine BHMT is 95%, 96%, 94% and 96% 
identical to human, bovine, rat and mouse BHMT, respectively, whereas the deduced 
amino acid sequence of porcine BHMT-2 is 88%, 87% and 87% identical to human, rat 
and mouse BHMT-2, respectively.  Over the sequences in which porcine BHMT and 
BHMT-2 align, they shared 78% amino acid identity which includes the Hcy binding 
domain and cysteine residues suggesting a common ancestral protein. However, relative 
to BHMT-2, BHMT has two additional regions of amino acid sequence; a 9 amino acid 
insertion (residues 86-94) in the N-terminal region and a 34 amino acid sequence 
(residues 373-407) at the carboxy terminus.  The 9 amino acid insertion in the N-terminal 
region of BHMT, which is missing in BHMT-2, is involved in conferring betaine 
specificity. When the specific region is removed from BHMT, the enzyme still binds Zn 
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but has no BHMT activity (Castro and Garrow, unpublished data).  Interestingly, this 
region has not been resolved in any of the crystal structures of BHMT solved to date 
(Evans et al., 2002; González et al., 2004) and has demonstrated sensitivity to partial 
trypsin digestion (Szegedi and Garrow, 2004), suggesting that this region displays 
considerable flexibility.  The additional 34 amino acids at the carboxy terminus of BHMT 
are critical for oligomerization.  The crystal structure of the rat enzyme has revealed this 
region to be involved in important dimer-dimer contacts (González et al. 2002; González 
et al., 2004), and studies with a mutant human enzyme, lacking these 34 amino acids, 
demonstrated that the enzyme was unstable, presumably because of its inability to 
oligomerize into a tetramer (Szegedi and Garrow, 2004).  As expected, both enzymes 
contain the Hcy binding domain profile (PS50970) containing the zinc-binding motif 
including cysteine 217, 299 and 300, and glutamate 159, which is an invariant residue in 
this family of proteins that has been shown to be required for interacting with the amino 
nitrogen of Hcy (Evans et al., 2002; Castro et al., 2004).  
The promoter region for porcine BHMT gene was detected in intron 1 and no 
TATA box was observed.  For humans the BHMT promoter region is positioned just 
upstream of the 5’ UTR (Park and Garrow, 1999).  A promoter region of 250 bases for 
the porcine BHMT-2 gene was detected and no TATA box was observed; however, 
previous findings have indicated that more than 50% of all promoters may lack a TATA 
box (Lewin, 2004).  Such TATA-less promoters often show multiple transcriptional sites 
resulting in differences in the UTR lengths. Thus, there is a possibility for the presence of 
splice variants of the porcine BHMT and BHMT-2 genes. 
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The BHMT 3’UTR varies across vertebrate species and ranged from 574 to 
1142bps, with humans having the longest 3’ UTR. The porcine BHMT cDNA contains 
several polyadenylation signals. The BHMT-2 3’ UTR was also variable among these 
species and ranged from 803 to 893 bps with pigs having the longest 3’ UTR (893 bps) 
(Table 6).  One polyadenylation signal was observed in the porcine BHMT-2 gene that 
could potentially give rise to transcripts 90 bases shorter than the observed porcine 
BHMT-2 transcript. These polyadenylation signals could give rise to splice variants that 
were not detected possibly due to low levels of expression or to the specific variants 
being present in other tissues.  For both BHMT and BHMT-2, 5’ UTRs in human, pig, 
mouse and rat and 3’ UTRs in human, pig, mouse and rat shared no significant similarity. 
Thus, ORF has been conserved but divergence exists in the untranslated regions during 
speciation similar to other mammalian genes (Zolfaghari and Ross, 2004).  
In pigs, organs such as lungs, heart and brain contained lower levels of BHMT 
mRNA compared to liver and kidney cortex, similar to the findings in other mammalian 
species (Delgado-Reyes et al., 2001). RT-qPCR revealed that porcine liver has 1.5-fold 
more BHMT mRNA than the kidney cortex. However, the porcine kidney cortex 
contained 3-fold more than liver BHMT-2 mRNA (Fig. 2.4). Both porcine BHMT and 
BHMT-2 genes contain CpG islands surrounding the transcriptional start site and 
overlapping the predicted promoters. Several mammalian genes contain CpG islands 
around the promoter region (Hannenhalli and Levy, 2001). Previous studies have shown 
that BHMT and BHMT-2 enzymes have significant activity in liver and kidney cortex 
and negligible in lungs, heart and brain (Sunden et al., 1997; Chadwick et al., 2000). 
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Methylation could be a factor associated with decreased transcription and thereby 
translation of BHMT and BHMT-2 protein. 
At present it is not known whether enzyme levels mirror mRNA levels for these 
different BHMT and BHMT-2 enzymes; however, it is known that the liver and kidney 
are primary sites for the metabolism of betaine and S-methylmethionine.  Previous 
studies have shown that BHMT protein represents 1 to 2% of total liver protein (Garrow, 
1996), which is consistent with its high level of mRNA.  However BHMT is catalytically 
sluggish when compared to its B12- and folate-dependent counterpart, MS (which also 
methylates Hcy) to form Met. MS is expressed at relatively low levels but has a turnover 
rate of ~1,000-fold greater than BHMT.  This chasm between enzyme level and catalytic 
efficiency of BHMT vs. methionine synthase suggests that BHMT might have other, 
currently unknown biological functions.  Since the carbon skeleton of HCY is both 
critical in regenerating the essential amino acid, Met, as well as being toxic if allowed to 
accumulate to high levels, it is possible that another critical function of BHMT, besides 
methylation, is to sequester HCY, thus preventing its oxidation and/or ability to initiate 
pathological processes.   
The expression pattern and organization of BHMT and BHMT-2 genes in pigs is 
similar to humans and thereby supports that the pig can be used as a model to study 
regulation and diseases associated with BHMT and BHMT-2 genes. 
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Figures and Tables 
 
Figure 2.1: Schematic depiction of genomic structure of porcine BHMT and BHMT-2 
genes. The vertically shaded boxes depict the predicted promoter region, the gray boxes 
represent the CpG islands, and black boxes represent exons (E). Scale is approximate.
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Figure 2.2: Comparison of amino acid sequences of porcine, rat, mouse and 
human BHMT (B1) and BHMT-2 (B2). Identical amino acids are not shaded and non-
identical amino acids are shaded dark grey. 
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Figure 2.3:  Quantification of BHMT expression using real time qRT-PCR in adult pig liver, 
kidney cortex, kidney medulla and lungs. Three replicates were performed for each sample. 
Negative controls (non-template control and minus reverse transcriptase control) were also run in 
triplicate. Each transcript was cloned into pCR2.1-TOPO (Invitrogen, Carlsbad, CA), and was 
verified by sequencing and used for construction of a standard curve. Each reaction contained 
100ng of cDNA. Absolute copy number was determined for each transcript. 
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Figure 2.4: Quantification of BHMT-2 expression using real time RT-PCR in adult pig liver and 
kidney cortex. Three replicates were performed for each sample. Negative controls (non-
template control and minus reverse transcriptase control) were also run in triplicates. Each 
transcript was cloned in pCR2.1-TOPO (Invitrogen, Carlsbad, CA), and was verified by 
sequencing and used for construction of a standard curve. Each reaction contained 100ng of 
cDNA. Absolute copy number was determined for each transcript. 
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Table 2.1: Primers used for amplifying porcine BHMT (B1) and BHMT-2 (B2) cDNA. 
 
Primer name Primer sequence Tm 
1-F TCCGTTTTCGAGTACCATCC 60 
1-R AAGGGCTGACTCATCAGGTG 60 
2-F TTTCGGCAGCAGTTAGAGGT 60 
2-R CCCAGATGGGCTTTTGAGTA 60 
3-F ACTTCCCCTATGTTCAGACCAC 60 
3-R CAGCTACACCAACCCAAGAA 60 
3’RACE-outer Supplied with kit 60 
B1- 3r-outer ACTTCCCCTATGTTCAGACCA 60 
3’RACE-inner Supplied with kit 60 
B1- 3r-inner ATCAGTTAAGACTGGGGAGCAG 60 
5’RACE-outer Supplied with kit 60 
B1-5r-outer TCCGTCTCCAATCACAACCT 60 
5’RACE-inner Supplied with kit 60 
B1-5r-inner ATATTCGAGGTGTCCGGATG 60 
4-F TTGGAGGACAAACCTAAGAAGC 60 
4-R AGAAGGGAATACTGGGAGAACC 60 
5-F AGTGAAGGACAGAAAGGTCTGC 60 
5-R TAACTCTGGAGAAGAGGGGCTA 60 
B2-5r-outer CCCGCTCTCAAGAATTCCAT 60 
B2-5r-inner TAGCCCCTCTTCTCCAGAGTTA 60 
B2-3r-outer CCCTGACGTCTCCAGCTACT 60 
B2-3r-inner GCACTGAACCCAGTGATGAA 60 
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Table 2.2: Primers used for Real time qRT-PCR. 
 
Primer name Primer sequence 
BHMT-f TGGTGGCAGGAGGTGTGA 
BHMT-r ACACTTTTTTGACTTCCGTTTCG 
B2-f GCCGTGGTAGAGCATCCAA 
B2-r GACATTCGATCCCGCTCTCA 
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 Table 2.3: Exon sizes of porcine BHMT and BHMT-2 gene. 
 
BHMT gene BHMT-2 gene 
Exon Exon size 
(bp) 
Amino acids Exon Exon size 
(bp) 
Amino 
acids 
1 197 11 1 50 11 
2 133 44 2 133 44 
3 119 40 3 92 31 
4 192 64 4 192 64 
5 148 49 5 148 49 
6 183 61 6 183 61 
7 229 77 7 229 77 
8 1329 61 8 975 26 
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Table 2.4: Elements detected in BHMT and BHMT-2 gene. 
 
 Number of 
elements 
    Length 
Occupied  (bp) 
Percentage of     
sequence (%) 
 BHMT BHMT-2 BHMT BHMT-2 BHMT BHMT-2 
SINEs 24 14 5088 3049 19.19 19.06 
MIRs 4 4 628 735 2.37 4.59 
LINEs 10 8 3295 1631 12.43 10.20 
LINE1 5 4 2269 1116 8.56 6.98 
LINE2 5 4 1026 515 3.87 3.22 
LTR elements 1 2 433 615 1.63 3.84 
ERVL-MaLRs 1 1 433 328 1.63 2.05 
ERV_classI - 1 - 287 - 1.79 
DNA elements 7 2 1180 219 4.45 1.37 
hAT-Charlie 5 - 763 - 2.88 - 
TcMar-Tigger 2 - 417 - 1.57 - 
Total interspersed 
repeats 
- - 9996 5514 37.71 34.47 
Simple repeats 1 2 50 71 0.19 0.44 
Low complexity 4 1 119 35 0.45 0.22 
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Table 2.5: Microsatellite markers observed in the porcine BHMT and BHMT-2 genes. 
 
Sequence Motif No.of Repeats SSR start SSR end Intron 
BHMT_1 ct 5 12322 12331 7 
BHMT_2 ga 5 21006 21015 5 
BHMT_3 gt 7 27828 27841 2 
BHMT_4 ta 14 27841 27868 2 
BHMT_5 ac 9 35587 35604 1 
BHMT2_1 gt 15 75740 75769 3 
BHMT2_2 ct 6 76407 76418 2 
 
+1 corresponds to the BAC sequence (CU468550) 
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Table 2.6: Differences in 3’ UTR length across species. 
 
Species 3’ UTR length for BHMT gene 
(bp) 
3’ UTR length for BHMT-2 gene 
(bp) 
Human 1189 892 
Pig 1142 893 
Rat 590 880 
Mouse 595 820 
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Chapter 3. Developmental regulation of porcine betaine homocysteine 
methyltransferase gene: evidence for a novel truncated BHMT splice variant 
 
Abstract 
 
 BHMT methylates Hcy using betaine and is detected in the liver and kidney 
cortex of humans and pigs. In order to exploit the pig biomedical model, the aim was to 
define the developmental expression pattern of BHMT enzyme in various porcine organs. 
Ten splice variants were observed in adult porcine liver, kidney cortex, kidney medulla, 
lungs, heart, brain and fetal lungs. These included two splice variants encoding a 
truncated BHMT enzyme. Quantitative real time PCR (qRT-PCR) analyses revealed that 
BHMT transcripts were expressed highest in the liver and kidney from day 45 of 
gestation (G45) until adulthood. The truncated BHMT transcripts represented ~5-13% of 
total BHMT transcripts in G30 fetus, G45 liver, adult liver and kidney cortex. A modeled 
structure of the truncated BHMT protein revealed, that unlike the wild type BHMT which 
is a (βα)8 barrel; a horseshoe fold conformation. The truncated BHMT protein thus would 
lack enzyme activity since it is missing residues required for enzyme activity. BHMT 
enzymatic activity was observed in G30 fetus and liver of G45, G90, adult pig and adult 
kidney cortex. Increased BHMT activity with age was observed. Further the methylation 
of three CpG sites and promoter region of BHMT gene was significantly higher in adult 
lungs compared with adult liver. Thus, methylation could be one of the factors 
contributing to decreased BHMT gene expression in lungs compared to liver in 
adulthood. 
Radhika Ganu, Timothy Garrow, Markos Koutmos, Laurie Rund, Lawrence B. Schook (2010) 
Developmental regulation of porcine betaine homocysteine methyltransferase gene: evidence for 
a novel truncated BHMT splice variant (in preparation).  
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Introduction 
 
BHMT catalyzes the conversion of Hcy to Met using betaine as the methyl donor.  
This enzyme is reportedly only found at appreciable levels in the liver and kidney cortex 
of adult humans and pigs, although detection by catalytic activity is hampered by the 
enzyme's extremely low turnover number.  The crystal structures of the human (Evans et 
al., 2002) and rat (Gonzalez et al., 2002) BHMT enzymes have been solved and the 
catalytic enzyme represents a dimer of dimers.  The human enzyme is encoded by 406 
amino acids.  The N-terminal region (about 300 amino acids) encodes a (β/α)8 barrel 
containing the active site. Residues Cys217, Cys299 and Cys300 are required for binding 
the catalytic zinc. The last forty-four residues are required for oligomerization (Evans et 
al., 2002).   
 BHMT is one of three mammalian enzymes known to remethylate Hcy to Met.  
Although BHMT-2 is highly related to BHMT, it utilizes S-methylmethionine rather than 
betaine as the methyl donor (Szegedi et al., 2008). Methionine synthase (MS) is a 
cobalamin-dependent enzyme that methylates Hcy using N5-methyltetrahydrofolate.  
Like BHMT, BHMT-2 has a low turnover number and has a limited tissue distribution, 
whereas MS is widely distributed and has a kcat 1000-fold greater than the BHMT 
enzymes.  These remethylation enzymes play a critical role in sustaining Met production 
for the synthesis of S-adenosylmethionine (SAM). SAM is the required methyl donor for 
a plethora of mammalian SAM-dependent methyltransferase enzymes (Petrossian TC, 
Clarke SG, 2010). A deficiency in Hcy remethylation can result in HHcy, a condition 
associated with increased risk for neural tube defects and adverse pregnancy outcomes, 
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including spina bifida and placental abruptions (Steegrers-Theunissen et al., 1991; 
Hague, 2003; Eskes, 1998; Mills et al., 1995; James et al., 1999; Ananth et al., 2007).  
It is intriguing that BHMT mRNA and enzyme are expressed at high levels in the 
liver (>1% of total soluble protein) and yet the protein has such a low turnover number.  
Therefore, it is possible that there are other potential roles for cellular BHMT 
independent of its methyltransferase activity. To date, no studies have determined 
whether BHMT splice variants are present in any species. Such an approach might 
provide insights into currently unknown secondary functions for this gene. 
The pig has been established as a good animal model to study several human 
diseases including diabetes, Alzheimer’s disease, and cancer (Tumbleson and Schook 
1996). Unlike rodents which express BHMT only in liver (Sunden et al., 1997; Delgado-
Reyes et al., 2001), pigs express BHMT in the same adult organs as humans. Thus the pig 
as a model could be used to explore the spatial and temporal expression and regulation of 
BHMT mRNA, including the possible expression of splice variants throughout 
development.  Herein, we report the first description of the pig BHMT splice variant that, 
if translated, would encode a protein we predict would have no methyltransferase 
activity. Also reported here is that promoter methylation could represent a regulatory 
mechanism for the spatial expression of BHMT in adulthood. 
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Materials and Methods 
 
RNA extraction and cDNA preparation  
 Liver, kidney cortex, kidney medulla, lungs, heart, and brain tissues were obtained 
from three Yorkshire pigs aged 7 months and in fasted state.  Total RNA was isolated 
from frozen tissues using a RNeasy Mini Kit (Qiagen, Valencia, CA).  Reverse 
transcription was carried out using random primers and a Bioline cDNA synthesis kit 
(Taunton, MA).  
 
Cloning and sequencing BHMT splice variants (SV) 
Based on the exonic regions of the porcine BHMT gene, three primer sets (Table 
1): BHMT-A-F, BHMT-A-R; BHMT-B-F, BHMT-B-R; BHMT-C-F and BHMT-C-R), 
were used to amplify the complete ORF of porcine BHMT. The 5’ and 3’ untranslated 
regions were amplified using total RNA and the FirstChoiceTM RNA ligase-mediated 
(RLM)-RACE kit (Ambion, Austin, TX).  This procedure used primers supplied with the 
kit and the nested gene-specific primers listed in Table 2.1. The 5’ UTR from all tissues 
was obtained using the primer sets: B1-5r-outer and 5'-RACE-outer; and B1-5r-inner and 
5' RACE inner primers. The 3’ UTR from liver was obtained using the primer sets: B1-
liver-3r-outer and 3'-RACE-outer; and B1-liver-3r-inner and 3' RACE inner primers. The 
3' UTR from adult kidney medulla, lungs, brain and heart cDNA following two rounds of 
amplification with the following primer sets: B1-Sv-3r-outer and 3'-RACE-outer; and 
B1-Sv-3r-inner and 3' RACE inner primers. These products were cloned into 
pCRTOPO2.1 vector and confirmed by sequencing. Analysis of cDNA sequences and 
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predicted protein sequences were carried out using the Biology Workbench 
(http://workbench.sdsc.edu/). MFOLD program, version 3.2 developed by Zuker and 
Turner (Zuker 2003); (http://www.bioinfo.rpi.edu/applications/mfold) was used to predict 
secondary structures and calculate free energy values. Poly AH software 
(http://www.softberry.ru/berry.phtml) was used to detect 3’ UTR poly A signal sites.  The 
potential miRNA sites were predicted using miRwalk (http://www.umm.uni-
heidelberg.de/apps/zmf/mirwalk/predictedmirnagene.html). The truncated BHMT protein 
modeling Phyre software (www.sbg.bio.ic.ac.uk/~phyre/) and the visual depictions were 
generated using the PyMOL Molecular Visualization System (DeLano Scientific LLC, 
Palo Alto, CA) 
 
Real time qRT-PCR of porcine BHMT SV 
  SV were quantified by RT-PCR using the SYBR Green PCR Mastermix.  Total 
mRNA was treated with RNase-free DNAse (Qiagen, Valencia, CA) to eliminate 
genomic contamination.  Reverse transcription was then carried out using the 
OmniscriptKit (Qiagen, Valencia, CA) (Chen et al. 2006).  Primers (Table 2.2) were 
designed using Primer Express software (Applied Biosystems, Foster city, CA).  The 
amount of BHMT SV in a given tissue was determined using the following primer sets; 
BHMT-exon4-F and BHMT-exon4-R. Transcripts sharing the exon 6 and exon 7 junction 
(SV1, SV2, SV4, SV5, SV7, SV8 and SV8) were measured using a primer located in the 
3’ end of exon 6 (BHMT-exon6-7F) and another primer annealing with the 5’ end of 
exon 7 (BHMT-exon6-7R).  In order to accurately quantify the truncated splice variants 
  
 56
(SV3 and SV6), a Taqman 5' nuclease assay (Applied Biosystems, Foster City, CA) using 
the primer pair BHMT-exon6-8-F and BHMT-exon6-8-R was performed.  The probe 
(BHMT-exon6-8-probe) was designed to anneal to the specific exon 6-exon 8 junction 
found only in SV3 and SV6 (Table 3.1).  Using these data, the percentage of transcripts 
encoding wild type (WT) BHMT (SV1, SV2, SV4, SV5, SV5, SV7, SV8 and SV9) and 
the truncated form of the enzyme (SV3 and SV6) was determined. The amount of 18S 
rRNA was used as an internal control and the data was also normalized to the amount of 
DNA present in each sample.   Three replicates were performed for each sample.  Each 
reaction contained 100ng of cDNA.  The negative controls (minus template or reverse 
transcriptase) were also run in triplicate. Data was normalized using 18S (Chen et al. 
2006) as an internal control and to the amount of genomic DNA/tissue/sample.  Splice 
variants were cloned into pCR2.1-TOPO (Invitrogen, Carlsbad, CA), verified by 
sequencing and used for the construction of standard curve.  The RT-PCR assay was 
performed using the ABI 7900HT fast real time PCR system (Applied Biosystems, Foster 
city, CA). Statistical analyses were performed using ANOVA (p <0.01). 
 
BHMT enzyme assay 
 The BHMT assay was performed using the method explained in Garrow (1996) with 
the following modifications. The betaine concentration used was 2mM and the incubation 
was performed at 37°C for 30 mins for adult liver, fetal (G90 and G45) liver and adult 
kidney cortex was and 2 hrs for G30 fetus, G45 & G90 kidney, lungs, heart and brain and 
adult lungs, heart and brain tissues. Samples from three animals were analyzed separately 
for each tissue.  
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Bisulfite sequencing of BHMT CpG island 
       Genomic DNA was isolated from liver and lungs of three adult pigs (sexually 
mature; 7 months) and three gestation day 90 embryos. EpiTect Bisulfite Kit (Qiagen, 
Valencia, CA) was used for bisulfite conversion of genomic DNA. The primers given in 
Table 3.2 were used to amplify BHMT CpG island. The PCR program used for primer 
Mp-1, Mp-2, Mp-4 is 94°C for 5 min; 35 cycles of 94°C for 30s, 52-56°C for 30s, 72°C 
for 1 min and a final cycle of 72°C for 10 mins. The pcr program used for primer Mp-3 is 
94°C for 5 min; 35 cycles of 94°C for 30s, 52.8°C for 3 mins, 72°C for 1 min and a final 
cycle of 72°C for 10 mins. The PCR products were then cloned into pCR2.1-TOPO 
(Invitrogen, Carlsbad, CA), sequenced using ABI Big Dye and the percentage of 
methylated (CpG) sites was determined. 
 
Results 
 
Analysis of BHMT splice variants and deduced amino acid sequences    
The RLM-RACE protocol was used to amplify cDNA sequences of the BHMT 
gene using total RNA isolated from adult liver, kidney cortex, kidney medulla, lungs, 
heart and brain.  These experiments revealed the presence of nine BHMT splice variants 
(Figure 3.1). The complete ORF of the BHMT gene was 1,224 bp long and encoded a 
protein of 407 amino acids with a calculated MW of 45 kD and a theoretical pI of 7.22. 
The truncated splice variants (SV3 and SV6) encode a protein that was missing 
approximately half of the 3' region of exon 6, all of exon 7, and small part of the 5' region 
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of exon 8.  These variants encode an ORF that is 850 bp shorter than SV1 and encodes a 
protein composed of 255 amino acids with a calculated MW of 28 KD and a pI of 6.43.             
   
5’UTR analysis and 3’UTR analysis  
The spatial and temporal differences in BHMT enzyme expression suggest the 
possibility of regulation in the promoter and/or 5’ UTR region. The leader sequences 
were predicted to have various secondary structures with free energies ranging from        
–19.5 to –59.4 kcal/mol. The free energy for the leader sequence in liver was –19.5 
kcal/mol; in contrast, the free energies predicted for the leader sequence found in heart 
vary in the range of –56.5 to –59.4 kcal/mol. The 5’ UTR in brain was 3bp shorter than 
liver 5’ UTR with similar secondary structure and free energy with that of 5’UTR found 
in liver. The length of UTRs and coding region are given in Table 4.  Sequencing 
detected varying 3’ UTR lengths (Figure 3.1).  This indicated that the termination sites 
varied depending upon the tissue. The porcine BHMT cDNA contained a consensus 
polyadenylation signal (ATTAAA) in the 3’UTR resulting in a 3’ UTR length of 1142 
bp. Also, two polyadenylation signals were detected at 530 and 1023 nucleotides 
downstream of the translational termination site in the 3’UTR. The kidney medulla, 
lungs, heart and brain had shorter 3’ UTRs compared to the liver. One potential miRNA 
(mmu-miR-686) was found in mouse BHMT 3’ UTR which was conserved in pig 3’ 
UTR (SV1 and SV2) which are found in liver and kidney cortex. 
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Tissue specific expression analyses of porcine BHMT splice variants 
To quantify and compare the tissue expression of BHMT splice variant 
transcripts, different primer pairs were employed to measure the known isoforms.  
Quantitative real-time PCR analysis revealed that adult porcine liver had the highest 
expression of total BHMT transcripts followed by kidney cortex.  The kidney medulla and 
lungs expressed significantly lower (P<0.01) BHMT transcripts compared to liver and 
kidney cortex. The adult heart and brain contained negligible levels of BHMT transcripts. 
In G45 fetal tissues, the expression followed similar trend with highest expression in liver 
and kidney and comparatively lower expression in lungs, heart and brain. In G90 fetal 
tissues, highest expression was in liver and kidney and no detectable expression was 
found in lungs, heart and brain. The relative ratio of transcripts with exon 7 to splice 
variants without exon 7 is given in Table 3.4. Thus, the expression of the SV3/SV6 
isoforms (combined), which encoded the truncated form of BHMT protein in liver 
represented biologically significant levels. In some tissues, the total of SV3/SV6 and 
SV1,2,4,5,7,8,9,10 exceeded the number of total BHMT transcripts (detected using 
primers in exon4) indicating there could be presence of splice variants that were not 
detected due to low expression levels. 
 
Modeled structure of “truncated” BHMT transcript 
  This study provides the first evidence for BHMT splice variants representing 5’ 
and 3’ variants associated with differences in tissue expression and levels of expression 
and two structural variants one of which encoding a truncated form of the protein.  The 
truncated variant was isolated from the kidney medulla (Figure 3.1, clone B1-SV3) and 
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heart (Figure 3.1, clone B1-SV6). An alignment with the wild type porcine BHMT 
peptide and the truncated peptide encoded by SV3 and SV6 revealed that if the truncated 
peptide is expressed and stable, the truncated peptide would lack BHMT activity since it 
is missing key residues required for catalysis, including cysteine 299 and cysteine 300, 
both of which are required for binding the catalytic Zn (13, 1).  Additional modeling of 
this truncated hypothetical protein using the Phyre software and PyMOL Molecular 
Visualization System (Figure 3.2a, 3.2b) suggested that the truncated variant only 
encodes part of the (βα)8 barrel that characterizes the wild type enzyme. It is missing the 
N-terminal α- helix, β-strand and αB helix, as well as the C-terminal α-helix and β-
strand. The truncated protein assumes a horseshoe fold rather than a barrel fold.   
 
Enzymatic activity of BHMT during development 
  The BHMT enzyme activity was observed to be highest in adult liver with 
specific activity of 123 units/mg of total protein, followed by adult kidney cortex 
measuring 28 units/mg of total protein. Kidney medulla and brain had the least specific 
activity of BHMT, measured at 5 units/mg of total protein each, whereas adult lungs 
showed no BHMT activity. The amount of BHMT specific activity in whole fetus at G30 
was 3 units /mg of total protein. Compared to adult liver, fetal liver (gestation age 45 and 
90) had BHMT specific activity of 5 and 11 units/mg of total protein respectively. Thus, 
during development BHMT activity showed an increasing trend with age. Even though 
immunohistochemistry showed presence of BHMT protein in fetal lungs; no other tissue 
(kidney, lungs, heart and brain) in fetuses of G45 and G90 showed presence of BHMT 
activity (Table 3.5). 
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Analysis of methylation status of CpG islands 
A CpG island (865 bp with 64.9% GC content) was also detected in the porcine 
BHMT gene. The CpG island started 100 bp upstream of the translational start site and 
contains exon 1 and part of intron 1. The methylation status of adult and G90 fetal liver 
and lungs was studied in order to understand whether methylation was one of the factors 
contributing to the spatial and temporal regulation of BHMT gene (Figure 3.4).  
The overall methylation of the CpG island was 5% for adult liver and 25% for 
adult lungs. The keys sites were -10,-67 and -69 which consisted of transcription factor 
binding sites (T-Ag and M2F1). In adult liver, none of these sites were methylated except 
for one out of 24 clones at site -69 ( 0.04% methylation). The part of the CpG island that 
covered the promoter region in adult liver was 10% methylated (43 out of 432 sites) but 
was 33.33% (144 out of 432 CpG sites) methylated in adult lungs. But incase of adult 
lungs -10 CpG site was 16% methylated and the -67 and -69 sites were 37.5% 
methylated. These are consistent with the relative expression of BHMT gene in adult liver 
and lungs (liver BHMT gene expression is 40 fold higher than in adult lungs). 
The overall methylation of the CpG island was 11% for G90 liver and 15% for 
G90 lungs. In fetal G90 liver at -10 CpG sites only one out of 24 clones was methylated 
(0.04%) whereas none for fetal G90 lung were methylated. In fetal liver -67 and -69 CpG 
sites were 0.04% and 0% methylated respectively. Whereas for fetal lungs -67 and -69 
CpG sites were 20% and 25% methylated respectively. The part of the CpG island that 
covered the promoter region in fetal liver was 13% methylated (59 out of 432 sites) but 
26% methylated (102 out of 432 CpG sites) in fetal lungs. 
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Discussion 
 
Previous immunohistochemical studies (Sunden et al., 1997) have demonstrated 
that BHMT is expressed only in adult pig liver and kidney cortex. BHMT peptide was 
below detection level in other organs including adult brain, pancreas, spleen, heart and 
lungs using the multiple detection systems (enzyme radioassay and Western blotting) 
employed to date. Using adult porcine tissues, our studies obtained the same result. 
Immunohistochemical staining of fetal tissue using the same polyclonal antibodies used 
in the Sunden et al., 1997 study, demonstrated the expression BHMT peptide in G30 and 
G90 fetal lungs (results not shown). No expression of BHMT was observed in negative 
controls (no polyclonal antibody). In order to elucidate the molecular mechanisms 
contributing to spatial and temporal changes in BHMT expression, BHMT cDNAs were 
amplified, cloned and sequenced from adult pig tissues and fetal lungs.  
Ten BHMT SVs that were expressed in different tissues were identified. Splicing 
increases protein diversity and more than three quarters of mammalian genes are 
alternatively spliced (Johnson et al., 2003). These SVs differed in length in the 5’ and 3’ 
UTRs as well as the coding region. Previously, studies have shown that the secondary 
structure of leader sequences with less than –50 kcal/mol free energy can reduce 
translation by 85-95% (Kozak, 1986). The free energy for the leader sequence in liver 
was –19.5 kcal/mol; where BHMT enzyme is most abundant. In contrast, the free 
energies predicted for the leader sequence found in heart varied in the range from –56.5 
to   –59.4 kcal/mol; where there is negligible BHMT activity. Various studies have shown 
that this blockage of translation by the stable secondary structure of a leader sequence can 
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be overcomed by truncating the long, GC rich 5’ UTR through splicing (charron et al., 
1998; Han et al., 2003a; Han et al., 2003b; Sasahara et al., 1998). This appears to be the 
case in the 5’ UTR of BHMT gene, where the 162 bp leader sequence in heart (61% GC 
content) is alternatively spliced whereas in liver it is 77 bp in length (52% GC content). 
However, the 5’ UTR in brain is 3bp shorter than liver 5’ UTR with similar secondary 
structure and free energy; suggesting potentially that other mechanisms in the brain 
which inhibits BHMT mRNA expression.  
The length of UTRs and coding region are given in Table 3.3. Sequencing 
detected varying 3’ UTR lengths (Figure 3.1). This indicated that the termination sites 
may vary depending on tissue source.  Those organs (kidney medulla, lungs, heart, brain) 
where BHMT enzyme activity is negligible demonstrated shorter 3’ UTRs compared to 
the liver BHMT SV, which had the longest 3’ UTR, and is the organ with the highest 
BHMT enzyme activity. Generally 3’ UTR harbor miRNA binding sites which can 
interfere which the stability and post-transcriptional regulation. One potential miRNA 
site was identified in mouse BHMT 3’UTR that was also conserved in pig BHMT 3’ 
UTR. These data suggest the possibility that the 3’ UTR length affects transcript stability 
and subsequently affects the level of enzyme activity (Thiele et al., 2006; Gaidatzis et al., 
2007; Majoros et al., 2007; Thorrez et al., 2010) 
 The BHMT enzyme has a low turnover of ~10/minute but is abundantly present 
(~1-1.5% of total protein) in liver in most mammalian species (Garrow, 1996). 
Expression of total BHMT transcripts and BHMT enzyme activity was highest in adult 
pig liver and kidney cortex in accordance with previous findings (Garrow, 1996). Even 
though BHMT transcripts were detected in adult kidney medulla, lungs, heart and brain, 
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no enzymatic activity was detected except in the brain. Interestingly BHMT transcripts 
and activity were detected even at G30, G45 and G90 of development. BHMT transcripts 
and activity increased with age in liver; the magnitude of expression and activity in adult 
liver was approximately 100 times higher than to fetal liver levels. Thus future studies to 
determine whether maternal diet and methylation pattern contributes to changes in fetal 
BHMT activity are warranted.  
Further, this study demonstrated that the truncated BHMT represented between 5-
13% of total BHMT transcripts in G30 fetuses, G45 liver, adult liver and kidney cortex. 
Additional modeling of this truncated peptide (Figure 3.2a, 3.3b) suggested that the 
truncated variant assumed a horseshoe fold rather than a barrel fold. The "wild type" 
BHMT protein has been extensively characterized including its crystal structure (Millian 
and Garrow, 1998; Castro et al., 2004; Evans et al., 2002). Based on its primary 
sequence, if expressed and stable, the truncated peptide would lack BHMT activity since 
it is missing key residues required for catalysis, including cysteine 299 and cysteine 300, 
both of which are required for binding catalytic Zn (Breska and Garrow 1999; Evans et 
al., 2002). Generally, horseshoe fold proteins function as chaperones or inhibitors, for 
example ribonuclease inhibitor protein (Papageorgiou et al., 1997). Thus, it could be 
postulated that the truncated BHMT protein could function as a chaperone or inhibitor.  
 The BHMT gene is involved in one carbon metabolism, which affects the 
methylation of DNA, RNA, histones and imprinting (Wolff et al., 1998; Xin et al., 2003; 
Niemitz and Feinberg, 2004). Methylation of the CpG island is known to decrease the 
transcription of the gene. Significant differences in the methylation of the liver and lungs 
CpG island in adult pigs were observed which corresponded to respective transcription 
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levels. Methylation affects transcription if the CpG sites overlapping transcription 
binding sites and promoter are methylated. Both these factors seem to affect the spatial 
expression of BHMT gene. Additional, reporter assays could confirm whether the 
predicted promoter methylation is responsible for spatial regulation of BHMT gene 
during adulthood. 
            The newly discovered splice variant could provide insights into potential 
alternative functions of the BHMT gene. This protein could possibly be involved in 
regulation by inhibiting BHMT enzyme activity. Methylation could be one of the factors 
responsible for decreased expression of BHMT gene in lungs thereby regulating tissue 
specific BHMT expression in adulthood. 
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Figures and Tables 
 
 
 
Figure 3.1: Splice variants (SV) of the BHMT gene. The black boxes represent the 5’ 
UTR, light grey boxes represent the exons 1-8 and the dark grey boxes represent the 3’ 
UTR. The black vertical lines depict region coding for the enzymatic region of BHMT 
protein and the black dotted region depicts the oligomerization domain. The letter 
represent L (liver); KC (kidney cortex); KM (kidney medulla); Lu (lungs); H (heart) and 
B (brian)  
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Figure 3.2a: The structural comparison of wild type human BHMT and truncated form of 
pig BHMT. (A) and (B) show the structure of wild type human BHMT (barrel only), and 
(C) and (D) show the Phyre-generated model of the truncated form of pig BHMT. 
 
 
 
 
  
 73
Figure 3.2b: Structural model of truncated BHMT. This truncation corresponds to a 
(βα)2-7 fragment of the full enzyme [(βα)1 and (βα)7 missing].  (A) (C) and (E) are 
views vertical to the axis of the barrel.  (B) (D) and (F) are views looking down the 
barrel.  The two sets of views are related by 90o rotation.  (C) and (D) are space filling 
models where the color scheme is as follows: white is carbon, blue is nitrogen, red is 
oxygen, and yellow is sulfur.  (E) and (F) are crude electrostatic potential surfaces, 
where negative charges are red, neutral is depicted as white, and positive as blue. 
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Figure 3.3: Absolute quantification of BHMT gene expression using real time 
RT-PCR and specific activity of BHMT during development. Absolute quantification of 
expression of BHMT gene using real time RT-PCR on left axis from 3 animals aged G30 
fetus, G45 (liver, kidney , lungs, heart and brain), G90 (liver, kidney , lungs, heart and 
brain) and adult liver, kidney cortex, kidney medulla, lungs, heart and brain. Three 
replicates were performed for each sample. Negative controls (non-template control and 
minus reverse transcriptase control) were also run in triplicates. Each transcript was 
verified by sequencing after being cloned in pCR2.1-TOPO (Invitrogen, Carlsbad, CA), 
and used for construction of standard curve. Each reaction contained 100ng of cDNA. 
The data was normalized to 18S RNA which was used and internal control and also to the 
amount of genomic DNA. The absolute copy numbers were determined for each 
transcript. The left axis depicts specific activity of BHMT enzyme from same 3 animals 
aged G30 fetus, G45 (liver, kidney, lungs, heart and brain), G90 (liver, kidney, lungs, 
heart and brain) and adult liver, kidney cortex, kidney medulla, lungs, heart and brain.  
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Figure 3.4: Methylation status of the BHMT CpG island. The CpG island consisting of 
72 CpG sites of the BHMT gene in (a) adult liver, (b) adult lung, (c) G90 liver and (d) 
G90 lungs. The open circles indicate unmethylated sites whereas black circles indicate 
methylated CpG sites. The black boxes indicate the putative transcriptional binding sites. 
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Tables 
 
Table 3.1: Primers used for real time qRT-PCR. 
 
Primer name Primer sequence 
BHMT-exon4-F TGGTGGCAGGAGGTGTGA 
BHMT-exon4-R ACACTTTTTTGACTTCCGTTTCG 
BHMT-exon6-7-F GGTTCATCGACCTGCCAGAA 
BHMT-exon6-7-R GAATGTCCCATCTGGTTGCAA 
BHMT-exon6-8-F GCAAACAGTGAAGCTCATGAAAGA 
BHMT-exon6-8-R CATCCGGCTTTGACATGGA 
BHMT-exon6-8-probe AGGCCATACAACCC 
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Table 3.2: Primers for bisulfite sequencing. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Primer 
name 
Forward Size 
(bp) 
Tm 
  Mp-1f GTTTTTTATATTTTTATAATTAGAGGAAGG 307 55.3 
Mp-1r AACTCCCTACCTACAAAATCCTC   
Mp-2f GATTTTGTAGGTAGGGAGTT 407 55.3 
Mp-2r AAACCCAATAAAAACCCTACAACTT   
Mp-3f TTTTTTTGGTTTTTTTGTTTTTAAT 341 52.8 
Mp-3r AACAAATAACAACCTACTTATTTTT   
Mp-4f GGGGTTATATAGTTTTAGGGGG 201 55.9 
Mp-4r ACCAAAAAAATAAATCTACAAAAACC   
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Table 3.3: Length of UTRs and coding region of BHMT splice variants. 
 
Splice 
Variant 
5’ UTR 
(nucleotide) 
Coding region 
(nucleotides) 
3’ UTR 
(nucleotide) 
1 77 1224 1142 
2 115 1224 79 
3 115 850 79 
4 77 1224 74 
5 162 1224 79 
6 162 850 79 
7 74 1224 79 
8 77 1224 927 
9 77 1224 79 
10 74 1224 74 
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Table 3.4: Relative ratios for the presence of splice variants. 
 
 Liver Kidney 
cortex 
Kidney 
medulla 
Lungs Heart 
SV 
6-7 
SV 
6-8 
SV 
6-7 
SV 
6-8 
SV 
6-7 
SV 
6-8 
SV 
6-7 
SV 
6-8 
SV 
6-7 
SV 
6-8 
 
G30 fetus 90
% 
10% 
 
 
G45 94
% 
6% 86% 13
% 
ND ND ND ND ND ND 
 
G90 86
% 
13%
* 
100
% 
ND ND ND ND ND ND ND 
 
Adult 88
% 
12% 92% 8% 100
% 
ND 100
% 
ND 4% ND 
 
 
ND= (not detectable) splice variants below detection levels 
* = Average from one animal 
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Table 3.5: BHMT activity during pig development. 
 
Age Tissue 
Specific activity 
(units/mg 
protein) 
g30 whole fetus 3± 0.7 
g45 liver 5± 1.3 
g90 liver 11± 2.2 
adult liver 123± 58.0 
adult kidney cortex 28± 9.6 
adult kidney medulla 5± 3.3 
adult brain 5± 2.5 
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Chapter 4. Evolutionary analysis and natural selection in betaine  
homocysteine methyltransferase (BHMT) and BHMT-2 genes 
Abstract 
 Betaine homocysteine methyltransferase gene (BHMT) and BHMT-2 
genes convert Hcy to Met using betaine and S-methylmethionine, respectively. BHMT 
and BHMT-2 genes are located tandem on the same chromosome in mammals. Inorder to 
identify conserved regions in the BHMT and BHMT-2 proteins that could play a 
functional role all available sequences of BHMT and BHMT-2 genes from 37 species of 
deuterostomes were compared. The BHMT gene was present in all analyzed genomes 
including the sea urchin, amphibians, reptiles, birds and mammals. However, the BHMT-
2 gene was present only in mammals, representing a gene duplication event of the BHMT 
gene, further characterized by the deletion of two DNA regions. These regions encode for 
important functional and structural divergence of these genes. Using several methods that 
test for selection, seven codon sites were observed to be positively selected. Selective 
pressure varied over lineages. The highest positive selection, as determined using dN/dS 
ratios, was observed in both BHMT and BHMT-2 following gene duplication in an 
ancestor to all extant mammals. The BHMT-2 gene has evolved at a faster rate than the 
BHMT gene. From these results, it was concluded that the BHMT-2 gene has evolved 
functionally following duplication of the BHMT gene and that selective pressure has 
varied across lineages. 
Radhika Ganu, Alfred Roca, Timothy Garrow, Lawrence Schook (2010). Evolutionary analysis and 
natural selection in betaine homocysteine methyltransferase (BHMT) and BHMT-2 genes (in 
preparation) 
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Introduction 
 
The BHMT, BHMT-2 and MS genes code for enzymes that convert Hcy to Met. 
BHMT, BHMT-2 and MS enzymes are zinc-dependent methyltransferases that methylate 
thiols or selenols (Breska and Garrow, 1999), and as their names suggest, BHMT and 
BHMT-2 are more closely related (percent genomic similarity) to each other than they 
are to MS.  
MS is approximately 100 fold more catalytically active than BHMT and BHMT-
2. However in liver, BHMT expression has been shown to reach 1-1.6% of the total 
soluble protein (Garrow, 1996). These enzymes are of interest due to an association of 
accumulation of Hcy with a number of diseases, cardiovascular disease, diabetes, 
hyperhomocystenemia, psoriasis and Alzheimer’s disease (Ueland and Refsum, 1989; 
Pajares and Perez-Sala, 2006; Chadwick et al.,2000; Ananth, 2007) suggesting they play 
a significant roles during development.  
 The BHMT enzyme is a tetramer that catalyzes an ordered bi bi reaction; Hcy 
binds to the enzyme, followed by betaine (trimethylglycine), and after catalysis the two 
products (dimethylglycine and Met) are released (Pajares and Perez-Sala, 2006). Due to 
the homology between BHMT-2 and BHMT, the former was assumed to methylate Hcy 
using betaine. However, a recent study has shown that BHMT-2 methylates Hcy using S-
methylmethionine (SMM), and cannot use betaine as a methyl donor (Szedegi et.al., 
2008).  Furthermore, unlike BHMT, BHMT-2 is a monomeric protein (Szegedi et al., 
2008) with a shorter peptide than BHMT. In the BHMT gene N-terminal there is an 
twenty-seven nucleotide sequence that codes for nine amino acids, which confers betaine 
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specificity to the BHMT enzyme. This particular region is absent in BHMT-2. Likewise, 
at the C-terminal there is a 102 nucleotide sequence coding for 34 amino acids involved 
in tetramerization of the BHMT enzyme and this region is also absent in BHMT-2. The 
crystal structures of several bacterial MS enzymes and of human and rat BHMT have 
been solved (Evans et al. 2002, Garrido et al. 2005).  The structure of the MS and BHMT 
enzymes differ substantially, although they share amino acids for Hcy and zinc binding. 
Most of the structural elements required for oligomerization in the C-terminal region of 
BHMT are absent in BHMT-2, which explains its monomeric structure (Szegedi et al., 
2008). 
Met is an essential amino acid. By converting Hcy to Met, methyltransferases 
perform a dual function of decreasing the amount of Hcy by converting to Met thereby 
increasing the amount of Met. Met then gets converted to S-adenosyl methionine which 
acts as a single carbon donor for ~200 reactions (Petrossian and Clarke, 2010). Betaine is 
the substrate for BHMT that is obtained from food sources like wheat, spinach, shellfish 
and sugar beets (Sakamoto et al., 2002; Zeisel et al., 2003) whereas S-methylmethionine 
is the substrate for BHMT-2 that is obtained from plant sources and lower organisms 
only. The following study is aimed at determining point in evolution when the 
duplication occurred in the BHMT and BHMT-2 genes and the selection of codons in 
these genes. 
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Materials and Methods 
 
Database search for coding sequences across species 
The BHMT and BHMT-2 sequences were obtained from Ensembl and NCBI 
Genbank. Human, rat and mouse BHMT and BHMT-2 sequences have been extensively 
characterized previously, and were used to align the sequences across species. The 
complete list of sequences with accession numbers and species classification in Table 4.1. 
The sequences were identified as BHMT and BHMT-2 using NCBI Blast algorithm 
(http://blast.ncbi.nlm.nih.gov/Blast.cgi). The sequence for zebra finch was annotated as a 
BHMT-2 gene; however our analysis suggest based on percent similarity and sequence 
characteristics that this was infact a BHMT gene. 
 
Multiple sequence alignment and phylogenetic analysis 
The sequences were aligned using the Geneious Pro program 
(http://www.geneious.com/) (Drummond et al., 2010). The protein sequences were 
aligned using the Blosum 62 algorithm. The settings for gap penalty and gap extension 
found to be most effective for proper alignment were 5 and 1, respectively. The 
alignment was then manually edited for accuracy in Geneious Pro. The first 12 amino 
acids and last 12 amino acids in the alignment were deleted before phylogenetic analysis 
since there was high degree of saturation in these regions across species making them 
impossible to align across taxa. The remaining coding sequences were then aligned using 
the option of alignment by translation. A phylogenetic tree was inferred using the 
Neighbor Joining method. The reference Jukes Cantor model was used to compute 
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genetic distance. Bootstrap values were calculated based on 100 pseudo replicates. 
Paracentrotus lividus (sea urchin) was used as an outgroup to root the NJ tree, since it 
was the only non-vertebrate species. 
 
Detection of recombination 
Using the Datamonkey server (http://www.datamonkey.org/dataupload.php), the 
BHMT and BHMT-2 alignment was uploaded. Bornean orangutan sequence was removed 
as it was identical to Sumatran orangutan. The best model of evolution that fit the data 
was determined using the Akaike information criterion (AIC) which was used for all 
subsequent analyses. Genetic Algorithm for Recombination (GARD) was used to detect 
the presence of recombination. GARD determines the number and position of 
recombination breakpoints and can then construct segment specific phylogenetic trees 
(Pond et al 2006). A Kishino-Hasegawa (KH) test (p value =0.01) was used to determine 
the statistical significance of recombination detected by GARD. Single breakpoint 
analysis (SBP) was performed to further confirm the presence of recombination. To 
identify the evidence of positive selection within the recombining fragments of the 
alignment, the PARRIS test was performed which identifies the dN:dS ratio with respect 
to recombination (Konrad et al., 2006).   
 
Gene conservation across and within species 
MultiPipMaker (http://pipmaker.bx.psu.edu/cgi-bin/multipipmaker) was used to 
demonstrate the genic and intergenic conserved regions of BHMT and BHMT-2 genes 
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within and across species. MultiPip plots and dot plots (http://pipmaker.bx.psu.edu/cgi-
bin/pipmaker?advanced) were generated using the default settings. 
 
Selection in BHMT and BHMT-2 genes 
To look for  evidence of selection in the evolution of BHMT and BHMT-2 genes, 
a number of methods were used including single likelihood ancestor counting (SLAC), 
random effects likelihood (REL), fixed effects likelihood (FEL) and internal fixed effects 
likelihood (IFEL). They were implemented using the Datamonkey web server (Pond and 
Frost, 2005b; Pond and Frost, 2006a). To examine the degree and type of selection 
occurring during the evolution of the genes; GA branch method was used which assigns 
values of dN/dS to every branch in an evolutionary tree (Pond and Frost, 2005c). Since 
only 25 sequences could be included in each GA branch analysis on the Datamonkey web 
server, we examined the sequences in three groups, each focusing on a different set of 
taxa. For all the above mentioned analyses the best model of evolution that fit the data 
was determined using the AIC. Gene trees were constrained to be consistent with known 
relationships among taxa as established by previous studies of fossil and DNA (Roca and 
Schook, 2010) (http://tolweb.org). 
 
Results 
 
Identification of BHMT and BHMT-2 gene sequences across species 
The human BHMT and BHMT-2 sequences have been sequenced completely and 
were used to identify BHMT sequences across species. The BHMT and BHMT-2 
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enzymes belong to the family S-methyltransferases enzymes (PF02574). BHMT and 
BHMT-2 have a Hcy-binding domain (PS50970) in previously characterized species. 
Sequences obtained from NCBI genbank and ensembl were found to have these regions 
in both the genes across all of the species used for the current study. The fish BHMT 
protein only had seven amino acids in the N-terminus as opposed to the nine amino acids 
that confer betaine specificity in mammals.  
 
Evolution of the BHMT and BHMT-2 genes 
The evolutionary history of BHMT and BHMT-2 genes has been not been 
described previously. The sea urchin, fish, amphibians, reptiles and birds did not have 
BHMT-2.  This suggested that duplication of the BHMT gene likely occurred after the 
divergence of birds and mammals, the star phylogeny in vertebrate BHMT and BHMT-2 
sequences indicates that these sequences were evolved little following duplication. The 
rodents seem to have a greater degree of divergence, most likely reflecting the faster 
evolutionary rates among the rodents.  Compared to BHMT, BHMT-2 seems to be 
evolving at faster rate. The BHMT and BHMT-2 sequences have conserved Hcy binding 
sites, consistent with their function of converting Hcy to Met using different substrates. A 
phylogenetic tree inferred from all BHMT and BHMT-2 sequences across all available 
species was constructed. Fig. 4.1 represents the phylogenetic tree generated using BHMT 
and BHMT-2 protein sequences. A similar tree was observed based on coding nucleotide 
sequences for BHMT and BHMT-2 genes. 
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Alignment of BHMT and BHMT-2 genes across species  
The multipip plots in Fig. 4.2 and Fig. 4.3 depicts the comparisons of BHMT and 
BHMT-2 genomic sequences from various species with human BHMT and BHMT-2. It is 
evident that as the evolutionary distance increased between species, the intronic regions 
lost similarities at a faster rate than the exonic regions. Interestingly, the least similar 
BHMT exon between human and opossum was exon 6, whereas between human and 
zebrafish it is exon 8 (Fig. 4.2). These exons encode amino acids involved in the 
tetramerization of the BHMT protein. Between human BHMT and BHMT-2, only the 
exonic regions were conserved, and the major differences observed were in exon 4 and 
exon 8. The higher degree of difference in exon 8 can be attributed to missing carboxy-
terminal amino acid sequences in BHMT-2.  Chimpanzee BHMT-2 has missing regions 
in intron 1 compared to human BHMT-2 suggesting recent deletions (Fig. 4.3).   
 
Recombination and its effect on BHMT and BHMT-2 genes 
The BHMT and BHMT-2 alignment was tested for evidence of recombination, 
utilizing three tests beginning with GARD.  GARD found evidence for two breakpoints, 
one at nucleotides 470 and 822 and other at nucleotide 794. A KH test was then 
performed which conferred significance (p value>0.01), with topological incongruence 
due to these breakpoints (Table 4.2). Further Single breakpoint (SBP) analysis was 
performed which described a single break point at nucleotide 791 (Table 4.3). The 
PARRIS test, which identifies proportion of dN>dS with respect to recombination was 
performed. No evidence of positive selection (P value >0.1) was identified within the 
recombining fragments of the alignment. 
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Recent evolution of BHMT and BHMT-2 genes in primates 
The dot plots in Fig. 4.4 depict evidence of recent evolutionary events in BHMT 
and BHMT-2 genes. The exonic regions were similar between human BHMT and BHMT-
2 genes. There was evidence of duplication in the genomic region between BHMT and 
BHMT-2 genes in chimapanzee, macaque, orangutan and marmoset. The line 
perpendicular to the slanting line demonstrates evidence of inversion in chimpanzee 
BHMT intron 4.  
 
Positive selection in BHMT and BHMT-2 genes 
Several models comparing synonymous and non-synonymous mutations were 
used to determine the presence of positive or purifying selection in BHMT and BHMT-2 
sequences (Table 4.5). A significance threshold of P<0.2 for SLAC, FEL, IFEL and 
posterior factor of >20 for REL (corresponding to p value of ~0.05) was employed. A 
total of seven codon sites representing different enzymatic domains were detected by at 
least one of the methods as undergone positive selection.  Amino acids 139, 142, 149, 
257, 290, 363 and 370 provided evidence of positively selection. Amino acids 149 and 
257 were identified by two methods as having undergone gene positive selection.  
Further, GA branch analysis determined that the highest selection occurred 
following the BHMT gene duplicated at the base of the mammalian lineage, forming two 
monophyletic clades of BHMT and BHMT-2 genes in mammals (Fig. 4.5).  
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Discussion 
 
Orthologous and paralogous BHMT and BHMT-2 protein sequences across 37 
species of deuterostomes were compared to obtain insights into the functional and 
structural evolution of these genes. BHMT was present in echinoderm, fish, amphibians, 
reptiles, birds and mammals whereas BHMT-2 was present only in mammals. Analyses 
showed that in all mammals BHMT-2 was a shorter peptide compared to BHMT. In 
mammals, the BHMT-2 gene was evolved at a faster rate compared to BHMT gene.  
From our study, we observed that BHMT-2 evolved following its duplication 
from BHMT in the lineage ancestral to all living mammals. In all the mammals, BHMT 
and BHMT-2 genes are located in tandem on the same chromosome (Garrow, 1996; 
Chadwick et al., 2000). Duplication is known to relieve selective pressure (Newman and 
Trask, 2003). Even though a faster enzyme (MS) was present to perform the same 
function; BHMT and BHMT-2 genes were retained during evolution suggesting that 
BHMT enzymes could have an alternate function which is not yet identified. Also, 
BHMT and BHMT-2 genes facilitate conversion of Hcy to Met by utilizing different 
substrates. Betaine is the substrate for BHMT that is obtained from food sources like 
wheat, spinach, shellfish and sugar beets (Sakamoto et al., 2002; Zeisel et al., 2003) 
whereas S-methylmethionine is the substrate for BHMT-2 that is obtained from plant 
sources and lower organisms only. Thus, mammals have acquired the ability to scavenge 
as much Met as possible from the environment. Duplication of BHMT gene has thereby 
offered mammals a selective advantage to obtain the Met, an essential amino acid from 
environment.   
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Studies for regulation of BHMT and BHMT-2 enzyme expression have revealed 
that there are differences within tissues in mammals. BHMT is expressed in liver and 
kidney cortex in humans and pigs (Suden et al., 1997; Delgado-Reyes et al., 2001), 
whereas only in liver incase of rats and interestingly in sheep the highest expression is 
seen in pancreas followed by liver (Xue and Snoswell, 1985). Thus, differential 
regulation of BHMT exists for ruminants and omnivores. These studies suggest that the 
expression of BHMT is associated with the diet.  Interestingly, another observation from 
our analyses was that the placental mammals and marsupials had BHMT-2 whereas the 
egg-laying animals did not have BHMT-2. There is a possibility that BHMT-2 has an 
important role during inutero development in placental mammals as all the dietary needs 
of the fetus is obtained through the placenta.   
Since accumulation of Hcy is associated with a number of diseases, BHMT could 
be conserved to adhere Hcy and maintain the plasma Hcy levels. Following duplication, 
changes in the protein sequence in BHMT-2 have provided new ligands sites possibly 
leading to more binding of Hcy and decreasing the plasma levels.  
Seven codons were inferred to be under positive selection of which five formed 
part of the enzymatic domain and two were in the oligomerization domain. Further 
mutational studies in these amino acids may be of interest for identifying whether these 
amino acids offered catalytic advantage over other amino acids. The highest rate of 
selection was observed at the internal branches immediately following the gene 
duplication that occurred before the divergence of living mammals. Thus, selection seems 
to be the driving force for functional divergence between BHMT and BHMT-2 genes. 
Gene sequences have been reported to undergo faster rates of evolution following gene 
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duplication, and this is observed in gene duplication of BHMT gene in mammals (Lynch 
and Conery, 2000; Ohta, 1994; Van de Peer et al., 2001). Thus, we conclude that the 
BHMT-2 gene resulted in mammals consequent to the duplication event followed by an 
accelerated rate of evolution.  
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Figures and Tables 
 
Figure 4.1: Phylogenetic analysis of BHMT and BHMT-2 sequences across species.  The sequences were aligned using 
Geneious Pro program. The protein sequences were aligned using Blosum 62. The alignment was then manually edited in Geneious 
Pro. The phylogenetic tree was constructed using Neighbor Joining method. The Jukes Cantor model was used to compute genetic 
distance. The support threshold percentage was 50 and the bootstrap was based on 100 pseudoreplicates. 
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Figure 4.2: Multipip plot for comparing BHMT genomic sequences across species with  
the human BHMT genomic sequence.  
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Figure 4.3: Multipip plot for comparing BHMT-2 genomic sequences across species with 
the human BHMT-2 genomic sequence.  
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Figure 4.4: Dot plots generated using advanced PipMaker to demonstrate recent 
evolutionary events in BHMT and BHMT-2 genomic sequences. The comparison is 
performed between human BHMT and BHMT-2 genomic sequences and (a) chimpanzee, 
(b) macaque, (c) orangutan and (d) marmoset. The inverse line in (d) indicates the BHMT 
and BHMT-2 genes are on reverse strand for marmoset. 
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Figure 4.5: Positive selection across lineages for BHMT and BHMT-2 sequences 
The phylogeny was specified using a Newick format and is based on known evolutionary 
relationships among the taxa. Legend depicts the percentages for branch classes in the 
proportion of total tree length (measured in expected substitutions per site per unit time) 
evolving under the corresponding value of dN/dS.  
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Tables 
Table 4.1: List of sequences, accession number and classification of all species analyzed. 
 
Common 
name 
Scientific 
names 
Class BHMT accession 
number 
BHMT-2 accession 
number 
Gilt-head 
bream  
Sparus aurata Actinopterygii DQ470488 - 
Pufferfish Tetraodon 
nigroviridis 
Actinopterygii ENSTNIT00000020044 - 
Zebrafish Danio rerio Actinopterygii ENSDART00000040422 - 
Olive 
flounder 
Paralichthys 
olivaceus 
Actinopterygii EF198069 - 
Atlantic 
salmon 
Salmo salar Actinopterygii NM_001139685 - 
Sea urchin Paracentrotus 
lividus 
Echinoidea DQ531773 - 
Western 
clawed frog 
Xenopus 
tropicalis 
Amphibia  BC089235 - 
African 
clawed frog 
Xenopus laevis Amphibia BC084414 - 
Anole 
lizard 
Anolis 
carolinensis 
Reptilia ENSACAT00000016842 - 
Chicken Gallus gallus Aves ENSGALT00000007194 - 
Zebra finch Taeniopygia 
guttata 
Aves ENSTGUT00000003947 - 
Platypus Ornithorhync
hus anatinus 
Mammalia ENSOANT00000012575 ENSOANT0000001
2577 
 
Opossum Monodelphis 
domestica 
Mammalia ENSMODT0000002505
8 
ENSMODT0000002
5059 
 
Lesser 
hedgehog 
tenrec  
 
Echinops 
telfairi 
 
Mammalia 
 
ENSETET00000012380 
 
ENSETET00000010
425 
 
Pig Sus scrofa Mammalia HQ130333 HQ130334 
Human Homo sapiens Mammalia ENST00000274353 ENST00000255192 
Mouse Mus musculus Mammalia ENSMUST00000084767 ENSMUST0000001
5941 
Rat Rattus 
norvegicus 
Mammalia ENSRNOT00000015336 ENSRNOT0000006
1708 
Sloth Choloepus 
hoffmanni 
Mammalia ENSCHOT00000010910 ENSCHOT0000001
4046 
Horse Equus 
caballus 
Mammalia ENSECAT00000016635 ENSECAT00000019
579 
Dog  Canis 
familiaris 
Mammalia ENSCAFT00000036198 ENSCAFT00000014
475 
Tarsier Tarsius 
syrichta 
Mammalia ENSTSYT00000003339 ENSTSYT00000004
821 
Sumatran 
Orangutan 
Pongo abelli 
 
    Mammalia NM_001133684 NM_001133705 
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Table 4.1 continued 
 
Common 
name 
Scientific 
name 
Class BHMT accession 
number 
BHMT-2 accession 
number 
Common 
Bottlenose 
Dolphin 
Tursiops 
truncatus 
 
  Mammalia  
- 
 
ENSTTRT00000012963 
 
Chimpanzee 
 
Pan 
troglodytes 
 
 
Mammalia 
 
ENSPTRT00000031558 
 
ENSPTRT00000031557 
Pika Ochotona 
princeps 
Mammalia ENSOPRT00000001600 - 
Shrew Sorex 
araneus 
Mammalia ENSSART00000010400 - 
Squirrel Spermo-
philus 
tridecem-
lineatus 
Mammalia - ENSSTOT00000005868 
Guinea pig Cavia 
porcellus 
Mammalia - ENSCPOT00000004310 
Microbat Myotis 
lucifugus 
Mammalia - ENSMLUT0000000914
9 
Bushbaby Otolemur 
garnettii 
Mammalia - ENSOGAT0000000863
2 
Kangaroo rat Dipodomys 
ordii 
Mammalia - ENSDORT0000000099
6 
Cow Bos taurus Mammalia ENSBTAT00000002916 - 
Marmoset Callithrix 
jacchus 
Mammalia ENSCJAT00000038806 ENSCJAT00000038798 
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Table 4.2: Kishino-Hasegawa (KH) testing report. 
 
Breakpoint LHS p-value RHS p-value 
470 0.00040 0.00160 
822 0.00040 0.00040 
 
At p = 0.01 there are 2 breakpoints with significant topological incongruence. 
LHS (left hand side) and RHS (right hand side) p-values were generated for each side of 
the breakpoint.  
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Table 4.3: Single breakpoint (SBP) analysis summary. 
 
Information 
Criterion Recombination 
IC 
improvement 
Breakpoint 
location 
Model 
averaged 
support 
AIC Yes 495.6 794 100.00% 
cAIC Yes 431.3 794 100.00% 
BIC No N/A N/A 0.00% 
 
AIC represents Akaike's information criterion; cAIC represents consistent 
Akaike's information criterion and BIC represents Bayesian information criterion. 
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Table 4.4: BHMT and BHMT-2 amino acid sites under positive selection. 
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Chapter 5 
Summary and Future research 
 
The importance of Hcy metabolism has been recognized during the past several 
decades due to its association with cardiovascular disease, Alzheimer’s disease, neural 
tube defects, psoriasis and diabetes (Pajares and Perez-Sala, 2006). The pig BHMT and 
BHMT-2 sequences have now been characterized and could be used to further study the 
functional roles of the enzymes during development as well as to construct transgenic 
pigs. BHMT constitutes approximately 1% of total liver protein (Garrow, 1996).  
Splicing is a mechanism that provides protein diversity in the mammalian 
genome. Thus, one gene can give rise to several protein products. We reported the 
presence of ten splice variants in different pig tissues suggesting temporal and spatial 
differences in BHMT gene expression during development. These included two splice 
variants encoding a truncated BHMT enzyme. Quantitative real time PCR analyses 
revealed that BHMT transcripts were expressed highest in both liver and kidney from day 
45 of gestation (G45) until adulthood. The truncated BHMT transcripts were represented 
~5-13% of total BHMT transcripts in G30 fetus, G45 liver, adult liver and kidney cortex. 
A modeled structure of the truncated BHMT protein revealed that it assumes a horseshoe 
fold conformation. Horseshoe fold proteins are known to function as inhibitors or 
chaperones (eg: RNase inhibitor). BHMT enzyme activity was observed in G30 fetus and 
liver of G45, G90, adult pig and adult kidney cortex. Thus, increased BHMT activity with 
age was observed.  
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Spatial regulation of BHMT and BHMT-2 enzyme expression has led to 
differences within tissues across mammals. BHMT is expressed in liver and kidney 
cortex in humans and pigs (Suden et al., 1997; Delgado-Reyes et al., 2001), whereas only 
in liver incase of rats and interestingly in sheep the highest expression is seen in pancreas 
followed by liver (Xue and Snoswell, 1985). These studies suggest that the expression of 
BHMT is associated with the diet. The methylation of three key CpG sites and 
methylation of promoter region of BHMT gene was significantly higher in adult porcine 
lungs compared with adult porcine liver. Thus, methylation could be one of the factors 
contributing to decreased BHMT gene expression in lungs compared to liver in 
adulthood. There is a possibility that the regulation is coordinated with histone 
modifications, which needs to be further validated.  
The BHMT-2 enzyme had been discovered a decade ago and was thought to 
function similarly to BHMT due to sequence homology. But recently it was discovered 
that although the function of BHMT-2 is similar to BHMT, i.e. BHMT-2 converts Hcy to 
methionine, it nonetheless utilizes a different substrate known as S-methylmethionine 
(Szegedi et al. 2008). Several studies have reported that the BHMT-2 enzyme degrades 
rapidly thereby limiting the understanding of this enzyme. Interestingly, our study shows 
that the BHMT-2 transcripts are expressed at a level three times higher in kidney cortex 
compared to liver. Further studies can determine if the enzyme activity reflects the 
transcript levels. These could provide insights into additional functions of the BHMT-2 
enzyme.  
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The sequence comparison of BHMT and BHMT-2 genes from 37 species of 
deuterostomes revealed that only BHMT sequences were found in sea urchin, amphibians, 
reptiles, birds and mammals, whereas the BHMT-2 gene was present only in the 
mammals. These findings suggest that the BHMT-2 gene may provide an advantage to 
mammals to scavenge as much as Met from the environment. Seven positively selected 
codon sites were also detected. Further mutation studies would help understand whether 
these amino acids are involved in improving the enzyme activity. Interestingly, another 
observation from our analyses was that the placental mammals and marsupials had 
BHMT-2 whereas the egg-laying animals did not have BHMT-2. There is a possibility 
that BHMT-2 has an important role during inutero development in placental mammals as 
all the dietary needs of the fetus is obtained through the placenta.  
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